Achondrogenesis Type II

Mendelian MONDO:0008702 Pathograph 29 Show in embeddings browser Achondrogenesis Type 2 Collagenopathy

COL2A1-related achondrogenesis, historically called achondrogenesis type II or Langer-Saldino achondrogenesis, is the perinatal-lethal end of the type II collagen disorder spectrum. Heterozygous COL2A1 variants disrupt cartilage matrix organization and endochondral ossification, producing profound fetal skeletal underdevelopment, a narrow thorax with pulmonary hypoplasia, and fetal or neonatal death. Hypochondrogenesis is a closely related but distinct diagnosis on a continuous severity spectrum.

Ask OpenScientist

Ask a research question about Achondrogenesis Type II. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
9
Pathophys.
1
Histopath.
25
Phenotypes
29
Pathograph
1
Genes
2
Variants
2
Medical Actions
3
Differentials
15
References
3
Deep Research
🏷

Classifications

ISDS Skeletal Nosology
type 2 collagen
👪

Inheritance

1
Autosomal dominant, usually arising as a new variant HP:0000006
ACG2 is autosomal dominant. Most reported affected fetuses have a new heterozygous COL2A1 variant, but parental gonadal or somatogonadal mosaicism can cause sibling recurrence; no fixed de novo or residual-recurrence percentage is assigned.
Autosomal dominant inheritance
Show evidence (3 references)
ORPHA:93296 SUPPORT Other
"Autosomal dominant"
Orphanet records autosomal-dominant inheritance for ACG2.
PMID:15054848 SUPPORT Human Clinical
"Achondrogenesis type II is a lethal skeletal dysplasia caused by new dominant mutations within the type II collagen gene (COL2A1)."
This family report supports the usual new-dominant presentation without quantifying its proportion.
PMID:17994563 SUPPORT Human Clinical
"This mutation was also found in the father, as a mosaic."
A clinically mild mosaic parent transmitted ACG2, demonstrating that parental mosaicism must be considered in recurrence counseling.
⚙

Pathophysiology

9
Heterozygous Pathogenic COL2A1 Variant
Definitive autosomal-dominant disease-causing COL2A1 variation initiates ACG2. Obligatory glycine substitutions are the predominant variant class in studied ACG2/hypochondrogenesis cohorts, while splice-site and in-frame deletion variants are also reported.
COL2A1 hgnc:2200 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves COL2A1 (hgnc:2200). hgnc:2200 is a gene from the HUGO Gene Nomenclature Committee.
extracellular matrix structural constituent GO:0005201 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves extracellular matrix structural constituent (GO:0005201). GO:0005201 is a molecular function from the Gene Ontology.
Downstream
Type II Collagen Triple-Helix Destabilization Glycine substitutions in the Gly-X-Y repeat disrupt the collagen triple helix; this is a common, not universal, molecular route in ACG2.
Show evidence (2 references)
CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z SUPPORT Other
"COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD | Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel | 2020-10-05T04:00:00.000Z"
ClinGen establishes the definitive dominant COL2A1 relationship.
PMID:10797431 SUPPORT Human Clinical
"Mutations in the COL2A1 gene were found in all 12 patients. Ten of the mutations were single base substitutions that converted a codon for an obligate glycine to a codon for an amino acid with a bulkier side chain."
A 12-patient series supports COL2A1 variation and the common glycine-substitution class.
Type II Collagen Triple-Helix Destabilization
In the common glycine-substitution route, replacement of an obligatory glycine destabilizes the type II procollagen triple helix. The graph does not assert this precise step for every splice or in-frame deletion allele.
chondrocyte CL:0000138 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves chondrocyte (CL:0000138). CL:0000138 is a cell type from the Cell Ontology.
collagen biosynthetic process GO:0032964 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves collagen biosynthetic process (GO:0032964). GO:0032964 is a biological process from the Gene Ontology.
Downstream
Chondrocyte Type II Collagen Retention and Poor Secretion Unstable abnormal type II collagen can be retained within chondrocytes and poorly secreted; this branch is based on specific studied cases rather than asserted for every ACG2 allele.
Show evidence (1 reference)
PMID:7829510 SUPPORT Human Clinical
"A transition of G2853 to A in exon 41 produced a substitution of Gly769 by Ser within the triple helical domain of the alpha 1(II) chain of type II collagen, interrupting the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple helical type II collagen molecules"
Direct biochemical evidence from one ACG2 fetus supports triple-helix disruption.
Chondrocyte Type II Collagen Retention and Poor Secretion
Some severe COL2A1 variants produce intracellular retention or reduced secretion of type II collagen. The magnitude of this defect is variant-specific and is not treated as universal.
growth plate cartilage chondrocyte CL:1000217 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves growth plate cartilage chondrocyte (CL:1000217). CL:1000217 is a cell type from the Cell Ontology.
endoplasmic reticulum GO:0005783 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves endoplasmic reticulum (GO:0005783). GO:0005783 is a cellular component from the Gene Ontology.
Downstream
Abnormal Cartilage Extracellular Matrix Reduced secretion and incorporation of normal type II collagen alters the cartilage extracellular matrix; the exact collagen composition varies by allele and clinical severity.
Show evidence (1 reference)
PMID:7829510 SUPPORT In Vitro
"However, cultured chondrocytes produced a trace amount of type II collagen, which was retained within the cells and not secreted."
Directly documents retention and failure of secretion for one Gly769Ser case.
Abnormal Cartilage Extracellular Matrix
ACG2 cartilage has abnormal matrix abundance, composition, and organization. Complete type II collagen loss with type I/III replacement occurs in some severe alleles, whereas other cases retain expressed type II collagen; the node therefore represents matrix dysfunction rather than universal collagen absence.
extracellular matrix organization GO:0030198 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves extracellular matrix organization (GO:0030198). GO:0030198 is a biological process from the Gene Ontology.
Downstream
Growth-Plate Architectural Disorganization Abnormal matrix and architectural disorganization co-occur in affected cartilage; the available histology does not establish their directionality.
Show evidence (2 references)
PMID:3309860 SUPPORT Human Clinical
"The extracellular matrix in the latter areas was more abundant and had characteristics of both precartilage mesenchymal matrix and typical cartilage matrix; it contained types I and II collagen, cartilage proteoglycan, fibronectin, and peanut agglutinin binding glycoconjugate(s)."
Seven ACG2 cases showed a mixed, heterogeneous cartilage matrix.
PMID:1515761 SUPPORT Human Clinical
"Collagen II was present, although heterogenously distributed throughout the cartilaginous matrix."
This milder case prevents overgeneralizing complete type II collagen absence.
Growth-Plate Architectural Disorganization
Epiphyseal and growth-plate cartilage is hypercellular, hypervascular, and structurally disorganized, with fibrous vascular canals and abnormal chondrocyte maturation patterns.
growth plate cartilage chondrocyte CL:1000217 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves growth plate cartilage chondrocyte (CL:1000217). CL:1000217 is a cell type from the Cell Ontology.
Downstream
Impaired Endochondral Ossification Disorganized cartilage compromises the template through which endochondral bone develops.
Show evidence (1 reference)
PMID:3309860 SUPPORT Human Clinical
"Some areas were comprised of vascular canals surrounded by extensive fibrous tissue and enlarged cells that had the appearance and histochemical characteristics of hypertrophic chondrocytes."
Describes the disorganized ACG2 growth-plate architecture.
Impaired Endochondral Ossification
Failure of endochondral bone development produces profound appendicular, axial, pelvic, and craniofacial skeletal underdevelopment.
cartilage development involved in endochondral bone morphogenesis GO:0060351 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves cartilage development involved in endochondral bone morphogenesis (GO:0060351). GO:0060351 is a biological process from the Gene Ontology. ossification GO:0001503 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves ossification (GO:0001503). GO:0001503 is a biological process from the Gene Ontology.
Downstream
Severe Micromelia
Short Long Bones
Hypoplastic Ilia
Absent Vertebral Body Mineralization
Unossified Sacrum
Delayed Pubic Bone Ossification
Metaphyseal Widening
Relative Macrocephaly
Short Neck
Protuberant Abdomen
Restricted Thoracic Growth
Show evidence (1 reference)
ORPHA:932 SUPPORT Other
"A rare group of lethal skeletal dysplasias characterized by an endochondral ossification deficiency that leads to dwarfism with extreme micromelia, a small thorax, a prominent abdomen, anasarca and polyhydramnios."
Supports deficient endochondral ossification as the central skeletal process.
Restricted Thoracic Growth
Deficient rib and axial skeletal growth produces short ribs and a narrow or bell-shaped thorax, constraining fetal lung development.
Downstream
Narrow Chest
Short Ribs
Bell-Shaped Thorax
Reduced Fetal Lung Development Thoracic restriction is a recognized prenatal predictor of reduced lung volume; the specific ACG2 source establishes their co-occurrence.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"Radiographical findings: short tubular bone with widened metaphyses and non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped chest, lack of ossification in pelvis and normal ossification of the skull."
A molecularly confirmed case documents the thoracic radiographic pattern.
Reduced Fetal Lung Development
Restricted thoracic growth is accompanied by pulmonary hypoplasia, leaving insufficient respiratory reserve after birth.
lung development GO:0030324 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves lung development (GO:0030324). GO:0030324 is a biological process from the Gene Ontology.
Downstream
Pulmonary Hypoplasia
Perinatal Respiratory Failure
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0002089 | Pulmonary hypoplasia | Frequent (79-30%)"
The subtype record supports pulmonary hypoplasia.
Perinatal Respiratory Failure
Pulmonary hypoplasia and thoracic restriction cause severe neonatal respiratory insufficiency, the proximate lethal pathway in liveborn cases.
Downstream
Neonatal Respiratory Distress
Respiratory Failure
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"The present case had significant respiratory distress immediately after birth, was followed with HFOV due to persistent respiratory distress during mechanical ventilation using conventional settings and the patient died of respiratory insufficiency on postnatal day 25."
A molecularly confirmed liveborn case documents the respiratory lethal pathway.
✶

Histopathology

1
Disorganized Growth Plate Cartilage
Epiphyseal and growth-plate cartilage is replaced by heterogeneous, hypervascular tissue containing fibrous canals and abnormally enlarged chondrocytes.
Show evidence (1 reference)
PMID:3309860 SUPPORT Human Clinical
"The normal architecture of the epiphyseal and growth plate cartilage was replaced by a morphologically heterogeneous tissue."
Seven ACG2 cases showed the characteristic cartilage disorganization.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Achondrogenesis Type II Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

25
Head and Neck 5
Midface Retrusion FREQUENT HP:0011800 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Midface retrusion (HP:0011800). HP:0011800 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0011800 | Midface retrusion | Frequent (79-30%)"
Orphanet lists midface retrusion as frequent.
Prominent Forehead HP:0011220 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent forehead (HP:0011220). HP:0011220 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"A physical examination revealed extremely short extremities, abdominal distention, a small chest, a prominent forehead and a flat nasal bridge (Figure 1)."
A molecularly confirmed liveborn case documents a prominent forehead.
Cleft Palate HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"A rare, lethal type of achondrogenesis, and part of the spectrum of type 2 collagen-related bone disorders, characterized by severe micromelia, short neck with large head, small thorax, protuberant abdomen, underdeveloped lungs, distinctive facial features such as a prominent forehead, a small..."
The subtype definition states that cleft palate occurs in some cases.
Relative Macrocephaly HP:0004482 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Relative macrocephaly (HP:0004482). HP:0004482 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20387359 SUPPORT Human Clinical
"Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large head, short neck and chest, prominent abdomen and short limbs."
Supports relative head enlargement without importing a parent-group frequency.
Short Neck HP:0000470 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short neck (HP:0000470). HP:0000470 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20387359 SUPPORT Human Clinical
"Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large head, short neck and chest, prominent abdomen and short limbs."
A type II case documents short neck without assigning a frequency.
Limbs 2
Severe Micromelia FREQUENT HP:0002983 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Micromelia (HP:0002983). HP:0002983 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0002983 | Micromelia | Frequent (79-30%)"
Orphanet lists micromelia as frequent in the subtype record.
Metaphyseal Widening HP:0003016 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Metaphyseal widening (HP:0003016). HP:0003016 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"an X-ray examination revealed a short tubular bone structure, metaphyseal widening, short ribs, a small chest and a lack of ossification in the pelvis"
A molecularly confirmed case documents metaphyseal widening.
Metabolism 2
Generalized Edema HP:0000969 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Edema (HP:0000969). HP:0000969 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:15054848 SUPPORT Human Clinical
"In the first pregnancy, severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation."
A familial ACG2 report documents generalized edema without assigning a frequency.
Hydrops Fetalis HP:0001789 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hydrops fetalis (HP:0001789). HP:0001789 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17994563 SUPPORT Human Clinical
"The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a septated cystic hygroma were obvious."
A molecularly confirmed familial case documents hydrops without assigning a frequency.
Musculoskeletal 3
Hypoplastic Ilia FREQUENT HP:0000946 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypoplastic ilia (HP:0000946). HP:0000946 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0000946 | Hypoplastic ilia | Frequent (79-30%)"
Orphanet lists hypoplastic ilia as frequent.
Narrow Chest FREQUENT HP:0000774 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Narrow chest (HP:0000774). HP:0000774 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0000774 | Narrow chest | Frequent (79-30%)"
Orphanet lists narrow chest as frequent.
Short Ribs FREQUENT HP:0000773 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short ribs (HP:0000773). HP:0000773 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0000773 | Short ribs | Frequent (79-30%)"
Orphanet lists short ribs as frequent.
Prenatal and Birth 1
Polyhydramnios HP:0001561 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Polyhydramnios (HP:0001561). HP:0001561 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"a detailed sonography scan revealed short long bones (<1st percentile for all long bones, including femur, tibia, fibula, humerus, radius and ulna) with a small thorax and polihydroamnios."
A molecularly confirmed case documents polyhydramnios without assigning a frequency.
Respiratory 3
Pulmonary Hypoplasia FREQUENT HP:0002089 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pulmonary hypoplasia (HP:0002089). HP:0002089 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0002089 | Pulmonary hypoplasia | Frequent (79-30%)"
Orphanet lists pulmonary hypoplasia as frequent.
Neonatal Respiratory Distress HP:0002643 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neonatal respiratory distress (HP:0002643). HP:0002643 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"The present case had significant respiratory distress immediately after birth, was followed with HFOV due to persistent respiratory distress during mechanical ventilation using conventional settings and the patient died of respiratory insufficiency on postnatal day 25."
A molecularly confirmed liveborn case documents immediate respiratory distress.
Respiratory Failure HP:0002878 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Respiratory failure (HP:0002878). HP:0002878 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"The patient died of respiratory insufficiency on postnatal day 25."
A molecularly confirmed liveborn case documents fatal respiratory insufficiency.
Other 9
Short Long Bones VERY_FREQUENT HP:0003026 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short long bone (HP:0003026). HP:0003026 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0003026 | Short long bone | Very frequent (99-80%)"
Orphanet lists short long bones as very frequent.
Absent Vertebral Body Mineralization FREQUENT HP:0004605 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Absent vertebral body mineralization (HP:0004605). HP:0004605 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0004605 | Absent vertebral body mineralization | Frequent (79-30%)"
Orphanet lists absent vertebral-body mineralization as frequent.
Unossified Sacrum FREQUENT HP:0030290 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Unossified sacrum (HP:0030290). HP:0030290 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0030290 | Unossified sacrum | Frequent (79-30%)"
Orphanet lists unossified sacrum as frequent.
Delayed Pubic Bone Ossification FREQUENT HP:0008788 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed pubic bone ossification (HP:0008788). HP:0008788 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0008788 | Delayed pubic bone ossification | Frequent (79-30%)"
Orphanet lists delayed pubic-bone ossification as frequent.
Bell-Shaped Thorax HP:0001591 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bell-shaped thorax (HP:0001591). HP:0001591 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"Radiographical findings: short tubular bone with widened metaphyses and non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped chest, lack of ossification in pelvis and normal ossification of the skull."
A molecularly confirmed case documents a bell-shaped chest.
Pulmonary Hypertension
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"An echocardiography performed on postnatal day 4 revealed pulmonary hypertension"
A molecularly confirmed liveborn case documents pulmonary hypertension.
Pierre-Robin Sequence FREQUENT HP:0000201 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pierre-Robin sequence (HP:0000201). HP:0000201 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"HP:0000201 | Pierre-Robin sequence | Frequent (79-30%)"
Orphanet lists Pierre-Robin sequence as frequent.
Protuberant Abdomen HP:0001538 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Protuberant abdomen (HP:0001538). HP:0001538 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20387359 SUPPORT Human Clinical
"Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large head, short neck and chest, prominent abdomen and short limbs."
A type II case documents the prominent abdomen.
Fetal Cystic Hygroma HP:0010878 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fetal cystic hygroma (HP:0010878). HP:0010878 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17994563 SUPPORT Human Clinical
"The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a septated cystic hygroma were obvious."
A molecularly confirmed familial case documents cystic hygroma.
🧬

Genetic Associations

1
COL2A1 (Causative)
Gene: COL2A1 hgnc:2200 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is COL2A1 (hgnc:2200). hgnc:2200 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (1 reference)
CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z SUPPORT Other
"COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD | Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel | 2020-10-05T04:00:00.000Z"
ClinGen classifies the COL2A1 relationship as definitive.
Variants (2)
Triple-helical glycine substitutions
The predominant studied class replaces an obligatory glycine in the COL2A1 Gly-X-Y repeat with an amino acid having a bulkier side chain.
Show evidence (1 reference)
PMID:10797431 SUPPORT Human Clinical
"Ten of the mutations were single base substitutions that converted a codon for an obligate glycine to a codon for an amino acid with a bulkier side chain."
Ten of 12 patients in this severe-spectrum series had glycine substitutions.
Splice-site and in-frame deletion variants
Less common severe-spectrum variants alter a consensus splice site or delete coding sequence in frame.
Show evidence (1 reference)
PMID:10797431 SUPPORT Human Clinical
"One of the mutations was a change in a consensus RNA splice site. Another was an 18-base pair deletion of coding sequences."
The same series documents these non-glycine-substitution classes.
🗃️

External Assertions

1
ClinGen COL2A1-achondrogenesis type II gene-disease validity assertion
ClinGen gene disease validity CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
The ClinGen Skeletal Disorders Gene Curation Expert Panel classifies the autosomal-dominant COL2A1 relationship with achondrogenesis type II as definitive.
Show evidence (1 reference)
CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z SUPPORT Other
"COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD | Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel | 2020-10-05T04:00:00.000Z"
This structured ClinGen assertion supports the gene, disease identity, mode of inheritance, and definitive validity classification.
💊

Medical Actions

2
Case-Based Neonatal Respiratory Support
Category: Therapeutic Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Intensive ventilatory support may be attempted in a liveborn infant, and nitric oxide was used after pulmonary hypertension was found in one case. Evidence documents use, not reversal of pulmonary hypoplasia or a survival benefit.
Target Phenotypes: Neonatal respiratory distress HP:0002643 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Neonatal respiratory distress (HP:0002643). HP:0002643 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31523626 SUPPORT Human Clinical
"The patient had severe respiratory distress, and follow-up was continued with high frequency oscillation ventilation (HFOV), as conventional mechanical ventilator settings failed to achieve the target saturation level."
Documents intensive respiratory support in one molecularly confirmed liveborn case.
PMID:31523626 SUPPORT Human Clinical
"An echocardiography performed on postnatal day 4 revealed pulmonary hypertension and the patient was administered nitric oxide"
Documents nitric oxide administration after case-level pulmonary hypertension was found.
Genetic Counseling and Mosaicism-Aware Recurrence Assessment
Category: Counseling / Informational Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Counseling should address dominant inheritance, the usual new-variant presentation, parental testing, and residual recurrence from gonadal or somatogonadal mosaicism.
Show evidence (2 references)
PMID:15054848 SUPPORT Human Clinical
"Although, we could not evaluate the presence of this mutation in the first fetus, we strongly believe that our data are in favor of germline mosaicism as the most likely explanation for the recurrence of type II achondrogenesis in both sibs."
Supports mosaicism-aware recurrence counseling.
PMID:31523626 SUPPORT Human Clinical
"The family was provided genetic counseling related to the high suspicion of lethal skeletal dysplasia."
Documents prenatal genetic counseling in a suspected lethal skeletal dysplasia pregnancy.
🔬

Diagnosis

3
Prenatal Ultrasound Detection
Ultrasound can identify a lethal skeletal dysplasia pattern, including severe micromelia or long-bone shortening, a small thorax, and fetal edema.
Show evidence (2 references)
PMID:15054848 SUPPORT Human Clinical
"In the first pregnancy, severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation."
Supports prenatal ultrasound detection.
PMID:20387359 SUPPORT Human Clinical
"Routine ultrasound screening made early detection and timely management possible."
Supports ultrasound as an early detection method.
Skeletal Radiographic Evaluation
Fetal or neonatal radiographs characterize the pattern of short tubular bones, short unfractured ribs, narrow bell-shaped thorax, and deficient vertebral and pelvic ossification, helping distinguish ACG2 from other lethal skeletal dysplasias.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"Radiographical findings: short tubular bone with widened metaphyses and non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped chest, lack of ossification in pelvis and normal ossification of the skull."
Documents the discriminating skeletal radiographic pattern.
COL2A1 Molecular Genetic Testing
Identification of a pathogenic heterozygous COL2A1 variant confirms the molecular diagnosis and enables targeted testing in a subsequent pregnancy when a familial variant is known.
molecular genetic testing NCIT:C19770 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:10797431 SUPPORT Human Clinical
"Mutations in the COL2A1 gene were found in all 12 patients."
Supports high diagnostic yield in this ACG2/hypochondrogenesis series.
PMID:15054848 SUPPORT Human Clinical
"Molecular analysis of genomic DNA extracted from amniotic cells of the second fetus revealed heterozygosity for a 1340G > A missense mutation (G316D) in the COL2A1 gene."
Demonstrates prenatal molecular confirmation from amniotic cells.
🩻

Imaging Findings

2
Prenatal ultrasound pattern of lethal skeletal underdevelopment
Prenatal ultrasound can detect severe long-bone shortening or micromelia, a small thorax, edema or hydrops, and polyhydramnios. These findings support suspicion of a lethal skeletal dysplasia but do not by themselves establish the molecular subtype.
Ultrasound
Show evidence (2 references)
PMID:15054848 SUPPORT Human Clinical
"In the first pregnancy, severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation."
Documents prenatal sonographic detection of classic ACG2 findings.
PMID:31523626 SUPPORT Human Clinical
"a detailed sonography scan revealed short long bones (<1st percentile for all long bones, including femur, tibia, fibula, humerus, radius and ulna) with a small thorax and polihydroamnios."
A molecularly confirmed case documents the composite ultrasound pattern.
Skeletal radiographic pattern of ACG2
Radiographs show short tubular bones with widened metaphyses, short usually unfractured ribs, a narrow bell-shaped thorax, and markedly deficient vertebral and pelvic ossification. Relative preservation of skull ossification can help distinguish classic ACG2, but it is not stated as invariant.
Xray Diagnostic
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"Radiographical findings: short tubular bone with widened metaphyses and non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped chest, lack of ossification in pelvis and normal ossification of the skull."
A molecularly confirmed case documents the discriminating radiographic pattern.
📈

Progression

2
Prenatal presentation
Age: First to second trimester onward
Severe limb shortening, edema, hydrops, or cystic hygroma may be detected prenatally, with the timing and combination varying among pregnancies.
Show evidence (2 references)
PMID:17994563 SUPPORT Human Clinical
"The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a septated cystic hygroma were obvious."
Demonstrates first-trimester detection in a molecularly confirmed family.
PMID:15054848 SUPPORT Human Clinical
"In the first pregnancy, severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation."
Demonstrates a classic second-trimester presentation.
Fetal or neonatal lethal course
Age: Fetal period through early neonatal life
Death commonly occurs in utero or early after birth. A liveborn infant in one molecularly confirmed report survived 25 days with intensive respiratory support, so the timing is not framed as uniformly immediate.
Show evidence (2 references)
PMID:31523626 SUPPORT Human Clinical
"Death occurs mostly in utero or during the early neonatal period [11]."
The report summarizes the usual fetal or early-neonatal lethal course.
PMID:31523626 SUPPORT Human Clinical
"The patient died of respiratory insufficiency on postnatal day 25."
Documents a liveborn course extending to 25 days.
📊

Prevalence

1
Worldwide
Point Prevalence Unknown
Subtype-specific prevalence has not been documented. Estimates for all achondrogenesis types, or for achondrogenesis combined with other lethal skeletal dysplasias, are not assigned to ACG2.
Show evidence (1 reference)
ORPHA:93296 SUPPORT Other
"Unknown | Worldwide | Point prevalence | ORPHANET"
The subtype-specific Orphanet record reports worldwide point prevalence as unknown.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Achondrogenesis Type II:

Achondrogenesis type IA
Overlapping Features Achondrogenesis IA overlaps through profound fetal skeletal shortening and severe ossification defects.
Distinguishing Features
  • Skull ossification is poor in type IA but relatively preserved in classic ACG2.
  • Rib fractures favor type IA; ACG2 classically has short unfractured ribs.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"The skull is not ossified in ACG1A, whereas there are mildly low ossified areas in ACG1B. Skull ossification is normal in ACG2, alongside decreased ossification in the pelvis and spine. Rib fractures are common in ACG1A, whereas short ribs are often without fractures in ACG2 [2, 4, 13]."
Provides the principal radiographic distinctions from type IA.
Achondrogenesis type IB
Overlapping Features Achondrogenesis IB shares a severe fetal skeletal presentation.
Distinguishing Features
  • Skull ossification is mildly reduced in type IB but relatively preserved in classic ACG2.
Show evidence (1 reference)
PMID:31523626 SUPPORT Human Clinical
"The skull is not ossified in ACG1A, whereas there are mildly low ossified areas in ACG1B. Skull ossification is normal in ACG2, alongside decreased ossification in the pelvis and spine."
Provides the principal radiographic distinction from type IB.
Hypochondrogenesis MONDO:0019669
Overlapping Features Hypochondrogenesis occupies the less severe end of a lethal skeletal dysplasia spectrum with substantial radiographic and histologic overlap.
Distinguishing Features
  • The ACG2-hypochondrogenesis boundary is continuous and may not be cleanly resolved.
Show evidence (1 reference)
PMID:3717210 SUPPORT Human Clinical
"These findings suggest that hypochondrogenesis and achondrogenesis type II represent a spectrum with marked phenotypic variability."
A 24-case study supports a continuous ACG2-hypochondrogenesis spectrum.
{ }

Source YAML

click to show 
name: Achondrogenesis Type II
creation_date: '2026-02-06T03:25:37Z'
category: Mendelian
synonyms:
- ACG2
- Achondrogenesis type 2
- Achondrogenesis, Langer-Saldino type
- COL2A1-related achondrogenesis
description: >-
  COL2A1-related achondrogenesis, historically called achondrogenesis type II
  or Langer-Saldino achondrogenesis, is the perinatal-lethal end of the type II
  collagen disorder spectrum. Heterozygous COL2A1 variants disrupt cartilage
  matrix organization and endochondral ossification, producing profound fetal
  skeletal underdevelopment, a narrow thorax with pulmonary hypoplasia, and
  fetal or neonatal death. Hypochondrogenesis is a closely related but distinct
  diagnosis on a continuous severity spectrum.
disease_term:
  preferred_term: achondrogenesis type II
  term:
    id: MONDO:0008702
    label: achondrogenesis type II
parents:
- Achondrogenesis
- Type 2 Collagenopathy
external_assertions:
- name: ClinGen COL2A1-achondrogenesis type II gene-disease validity assertion
  source: ClinGen
  assertion_type: gene_disease_validity
  external_id: CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
  description: >-
    The ClinGen Skeletal Disorders Gene Curation Expert Panel classifies the
    autosomal-dominant COL2A1 relationship with achondrogenesis type II as
    definitive.
  evidence:
  - reference: CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
    reference_title: COL2A1 / achondrogenesis type II (Definitive)
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD |
      Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel |
      2020-10-05T04:00:00.000Z
    explanation: >-
      This structured ClinGen assertion supports the gene, disease identity,
      mode of inheritance, and definitive validity classification.

inheritance:
- name: Autosomal dominant, usually arising as a new variant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    ACG2 is autosomal dominant. Most reported affected fetuses have a new
    heterozygous COL2A1 variant, but parental gonadal or somatogonadal mosaicism
    can cause sibling recurrence; no fixed de novo or residual-recurrence
    percentage is assigned.
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Autosomal dominant
    explanation: Orphanet records autosomal-dominant inheritance for ACG2.
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Achondrogenesis type II is a lethal skeletal dysplasia caused by new
      dominant mutations within the type II collagen gene (COL2A1).
    explanation: >-
      This family report supports the usual new-dominant presentation without
      quantifying its proportion.
  - reference: PMID:17994563
    reference_title: 'A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: This mutation was also found in the father, as a mosaic.
    explanation: >-
      A clinically mild mosaic parent transmitted ACG2, demonstrating that
      parental mosaicism must be considered in recurrence counseling.

classifications:
  isds_skeletal_category:
  - classification_value: type_2_collagen
    notes: >-
      ISDS Nosology and Classification of Genetic Skeletal Disorders, 2019
      revision (Mortier et al., PMID:31633310), Table 1 group 2 "Type 2 collagen
      group"; listed as "Achondrogenesis type 2 (Langer-Saldino)".
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: UNKNOWN
  notes: >-
    Subtype-specific prevalence has not been documented. Estimates for all
    achondrogenesis types, or for achondrogenesis combined with other lethal
    skeletal dysplasias, are not assigned to ACG2.
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Unknown | Worldwide | Point prevalence | ORPHANET
    explanation: >-
      The subtype-specific Orphanet record reports worldwide point prevalence
      as unknown.

progression:
- phase: Prenatal presentation
  age_range: First to second trimester onward
  notes: >-
    Severe limb shortening, edema, hydrops, or cystic hygroma may be detected
    prenatally, with the timing and combination varying among pregnancies.
  evidence:
  - reference: PMID:17994563
    reference_title: 'A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a
      septated cystic hygroma were obvious.
    explanation: Demonstrates first-trimester detection in a molecularly confirmed family.
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the first pregnancy, severe micromelia and generalized edema were noted
      on ultrasound at 21 weeks' gestation.
    explanation: Demonstrates a classic second-trimester presentation.
- phase: Fetal or neonatal lethal course
  age_range: Fetal period through early neonatal life
  notes: >-
    Death commonly occurs in utero or early after birth. A liveborn infant in
    one molecularly confirmed report survived 25 days with intensive
    respiratory support, so the timing is not framed as uniformly immediate.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Death occurs mostly in utero or during the early neonatal period [11].
    explanation: The report summarizes the usual fetal or early-neonatal lethal course.
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The patient died of respiratory insufficiency on postnatal day 25.
    explanation: Documents a liveborn course extending to 25 days.

pathophysiology:
- name: Heterozygous Pathogenic COL2A1 Variant
  description: >-
    Definitive autosomal-dominant disease-causing COL2A1 variation initiates
    ACG2. Obligatory glycine substitutions are the predominant variant class in
    studied ACG2/hypochondrogenesis cohorts, while splice-site and in-frame
    deletion variants are also reported.
  genes:
  - preferred_term: COL2A1
    term:
      id: hgnc:2200
      label: COL2A1
  molecular_functions:
  - preferred_term: extracellular matrix structural constituent
    term:
      id: GO:0005201
      label: extracellular matrix structural constituent
  evidence:
  - reference: CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
    reference_title: COL2A1 / achondrogenesis type II (Definitive)
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD |
      Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel |
      2020-10-05T04:00:00.000Z
    explanation: ClinGen establishes the definitive dominant COL2A1 relationship.
  - reference: PMID:10797431
    reference_title: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutations in the COL2A1 gene were found in all 12 patients. Ten of the
      mutations were single base substitutions that converted a codon for an
      obligate glycine to a codon for an amino acid with a bulkier side chain.
    explanation: A 12-patient series supports COL2A1 variation and the common glycine-substitution class.
  downstream:
  - target: Type II Collagen Triple-Helix Destabilization
    causal_link_type: DIRECT
    description: >-
      Glycine substitutions in the Gly-X-Y repeat disrupt the collagen triple
      helix; this is a common, not universal, molecular route in ACG2.
    evidence:
    - reference: PMID:26443184
      reference_title: Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        One-third of the mutations are dominant-negative mutations that affect
        the glycine residue in the G-X-Y repeats of the alpha 1 chain. These
        mutations disrupt the collagen triple helix and are common in
        achondrogenesis type II and hypochondrogenesis.
      explanation: A large variant review directly supports this common dominant-negative route.

- name: Type II Collagen Triple-Helix Destabilization
  description: >-
    In the common glycine-substitution route, replacement of an obligatory
    glycine destabilizes the type II procollagen triple helix. The graph does
    not assert this precise step for every splice or in-frame deletion allele.
  biological_processes:
  - preferred_term: collagen biosynthetic process
    term:
      id: GO:0032964
      label: collagen biosynthetic process
  cell_types:
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  evidence:
  - reference: PMID:7829510
    reference_title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A transition of G2853 to A in exon 41 produced a substitution of Gly769 by
      Ser within the triple helical domain of the alpha 1(II) chain of type II
      collagen, interrupting the mandatory Gly-X-Y triplet sequence required for
      the normal formation of stable triple helical type II collagen molecules
    explanation: Direct biochemical evidence from one ACG2 fetus supports triple-helix disruption.
  downstream:
  - target: Chondrocyte Type II Collagen Retention and Poor Secretion
    causal_link_type: DIRECT
    description: >-
      Unstable abnormal type II collagen can be retained within chondrocytes and
      poorly secreted; this branch is based on specific studied cases rather
      than asserted for every ACG2 allele.
    evidence:
    - reference: PMID:7829510
      reference_title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A transition of G2853 to A in exon 41 produced a substitution of Gly769 by
        Ser within the triple helical domain of the alpha 1(II) chain of type II
        collagen, interrupting the mandatory Gly-X-Y triplet sequence required for
        the normal formation of stable triple helical type II collagen molecules
      explanation: Identifies the triple-helix-disrupting Gly769Ser variant in the studied fetus.
    - reference: PMID:7829510
      reference_title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        However, cultured chondrocytes produced a trace amount of type II
        collagen, which was retained within the cells and not secreted.
      explanation: Cultured chondrocytes from the same case directly showed retention and failed secretion.

- name: Chondrocyte Type II Collagen Retention and Poor Secretion
  description: >-
    Some severe COL2A1 variants produce intracellular retention or reduced
    secretion of type II collagen. The magnitude of this defect is
    variant-specific and is not treated as universal.
  cell_types:
  - preferred_term: growth plate cartilage chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  cellular_components:
  - preferred_term: endoplasmic reticulum
    term:
      id: GO:0005783
      label: endoplasmic reticulum
  evidence:
  - reference: PMID:7829510
    reference_title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      However, cultured chondrocytes produced a trace amount of type II
      collagen, which was retained within the cells and not secreted.
    explanation: Directly documents retention and failure of secretion for one Gly769Ser case.
  downstream:
  - target: Abnormal Cartilage Extracellular Matrix
    causal_link_type: DIRECT
    description: >-
      Reduced secretion and incorporation of normal type II collagen alters the
      cartilage extracellular matrix; the exact collagen composition varies by
      allele and clinical severity.
    evidence:
    - reference: PMID:7829510
      reference_title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Type I and III collagens were the major species found in cartilage tissue
      explanation: Human cartilage tissue showed variant-specific replacement of type II collagen.

- name: Abnormal Cartilage Extracellular Matrix
  description: >-
    ACG2 cartilage has abnormal matrix abundance, composition, and
    organization. Complete type II collagen loss with type I/III replacement
    occurs in some severe alleles, whereas other cases retain expressed type II
    collagen; the node therefore represents matrix dysfunction rather than
    universal collagen absence.
  biological_processes:
  - preferred_term: extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  evidence:
  - reference: PMID:3309860
    reference_title: Achondrogenesis type II, abnormalities of extracellular matrix.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The extracellular matrix in the latter areas was more abundant and had
      characteristics of both precartilage mesenchymal matrix and typical
      cartilage matrix; it contained types I and II collagen, cartilage
      proteoglycan, fibronectin, and peanut agglutinin binding glycoconjugate(s).
    explanation: Seven ACG2 cases showed a mixed, heterogeneous cartilage matrix.
  - reference: PMID:1515761
    reference_title: 'Collagen type II in Langer-Saldino achondrogenesis: absence of major abnormalities in a less severe case.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Collagen II was present, although heterogenously distributed throughout
      the cartilaginous matrix.
    explanation: This milder case prevents overgeneralizing complete type II collagen absence.
  downstream:
  - target: Growth-Plate Architectural Disorganization
    causal_link_type: UNKNOWN
    description: >-
      Abnormal matrix and architectural disorganization co-occur in affected
      cartilage; the available histology does not establish their directionality.
    evidence:
    - reference: PMID:3309860
      reference_title: Achondrogenesis type II, abnormalities of extracellular matrix.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The normal architecture of the epiphyseal and growth plate cartilage was
        replaced by a morphologically heterogeneous tissue.
      explanation: Histology documents co-occurring abnormal matrix and architectural disorganization.

- name: Growth-Plate Architectural Disorganization
  description: >-
    Epiphyseal and growth-plate cartilage is hypercellular, hypervascular, and
    structurally disorganized, with fibrous vascular canals and abnormal
    chondrocyte maturation patterns.
  cell_types:
  - preferred_term: growth plate cartilage chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  evidence:
  - reference: PMID:3309860
    reference_title: Achondrogenesis type II, abnormalities of extracellular matrix.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Some areas were comprised of vascular canals surrounded by extensive
      fibrous tissue and enlarged cells that had the appearance and
      histochemical characteristics of hypertrophic chondrocytes.
    explanation: Describes the disorganized ACG2 growth-plate architecture.
  downstream:
  - target: Impaired Endochondral Ossification
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Failure of the cartilage growth-plate template to support normal bone formation
    description: >-
      Disorganized cartilage compromises the template through which
      endochondral bone develops.
    evidence:
    - reference: PMID:22859705
      reference_title: Hypertrophic chondrocytes have a limited capacity to cope with increases in endoplasmic reticulum stress without triggering the unfolded protein response.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Longitudinal bone growth is dependent on the strict temporal regulation
        and control of chondrocyte differentiation, proliferation, hypertrophy,
        apoptosis, and vascular invasion within the growth plate. Disturbances
        to this coordinated process cause a large number of skeletal growth disorders.
      explanation: Mouse-study background biology supports this general intervening mechanism, not ACG2-specific human causation.

- name: Impaired Endochondral Ossification
  description: >-
    Failure of endochondral bone development produces profound appendicular,
    axial, pelvic, and craniofacial skeletal underdevelopment.
  biological_processes:
  - preferred_term: cartilage development involved in endochondral bone morphogenesis
    term:
      id: GO:0060351
      label: cartilage development involved in endochondral bone morphogenesis
  - preferred_term: ossification
    term:
      id: GO:0001503
      label: ossification
  evidence:
  - reference: ORPHA:932
    reference_title: Achondrogenesis
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A rare group of lethal skeletal dysplasias characterized by an
      endochondral ossification deficiency that leads to dwarfism with extreme
      micromelia, a small thorax, a prominent abdomen, anasarca and
      polyhydramnios.
    explanation: Supports deficient endochondral ossification as the central skeletal process.
  downstream:
  - target: Severe Micromelia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Failure of long-bone growth through the cartilage growth plate
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0002983 | Micromelia | Frequent (79-30%)
      explanation: The subtype record supports micromelia as a core ACG2 phenotype.
  - target: Short Long Bones
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Reduced longitudinal growth at long-bone growth plates
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Typical radiological findings of ACG2 include short long bones, short
        ribs without fractures, decreased ossification of the pelvis and spine,
        and normal mineralization in the iliac and calvarial bones [3].
      explanation: A clinical report summarizes the characteristic short long bones.
  - target: Hypoplastic Ilia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Deficient pelvic cartilage-template growth and mineralization
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0000946 | Hypoplastic ilia | Frequent (79-30%)
      explanation: The subtype record supports hypoplastic ilia.
  - target: Absent Vertebral Body Mineralization
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Deficient axial endochondral mineralization
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0004605 | Absent vertebral body mineralization | Frequent (79-30%)
      explanation: The subtype record supports absent vertebral-body mineralization.
  - target: Unossified Sacrum
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Deficient sacral endochondral mineralization
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0030290 | Unossified sacrum | Frequent (79-30%)
      explanation: The subtype record supports absent sacral ossification.
  - target: Delayed Pubic Bone Ossification
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Deficient pelvic endochondral mineralization
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0008788 | Delayed pubic bone ossification | Frequent (79-30%)
      explanation: The subtype record supports delayed pubic-bone ossification.
  - target: Metaphyseal Widening
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Abnormal metaphyseal modeling at disorganized growth plates
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        an X-ray examination revealed a short tubular bone structure,
        metaphyseal widening, short ribs, a small chest and a lack of
        ossification in the pelvis
      explanation: A molecularly confirmed liveborn case documented metaphyseal widening.
  - target: Relative Macrocephaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20387359
      reference_title: Antenatal diagnosis of achondrogenesis type II.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Prenatal ultrasonography at 22-weeks gestation revealed a fetus with
        large head, short neck and chest, prominent abdomen and short limbs.
      explanation: A type II case documents a large head relative to the profoundly short body.
  - target: Short Neck
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20387359
      reference_title: Antenatal diagnosis of achondrogenesis type II.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Prenatal ultrasonography at 22-weeks gestation revealed a fetus with
        large head, short neck and chest, prominent abdomen and short limbs.
      explanation: A type II case documents short neck.
  - target: Protuberant Abdomen
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20387359
      reference_title: Antenatal diagnosis of achondrogenesis type II.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Prenatal ultrasonography at 22-weeks gestation revealed a fetus with
        large head, short neck and chest, prominent abdomen and short limbs.
      explanation: A type II case documents the prominent abdomen.
  - target: Restricted Thoracic Growth
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Deficient rib and axial-skeletal growth
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A rare, lethal type of achondrogenesis, and part of the spectrum of type
        2 collagen-related bone disorders, characterized by severe micromelia,
        short neck with large head, small thorax, protuberant abdomen,
        underdeveloped lungs, distinctive facial features such as a prominent
        forehead, a small chin, a cleft palate (in some) and distinctive
        histological features of the cartilage.
      explanation: The subtype definition links severe skeletal disease with a small thorax.

- name: Restricted Thoracic Growth
  description: >-
    Deficient rib and axial skeletal growth produces short ribs and a narrow or
    bell-shaped thorax, constraining fetal lung development.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Radiographical findings: short tubular bone with widened metaphyses and
      non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped
      chest, lack of ossification in pelvis and normal ossification of the skull.
    explanation: A molecularly confirmed case documents the thoracic radiographic pattern.
  downstream:
  - target: Narrow Chest
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0000774 | Narrow chest | Frequent (79-30%)
      explanation: The subtype record supports narrow chest.
  - target: Short Ribs
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0000773 | Short ribs | Frequent (79-30%)
      explanation: The subtype record supports short ribs.
  - target: Bell-Shaped Thorax
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Radiographical findings: short tubular bone with widened metaphyses and
        non ossified cervical vertebrae, short unfractured ribs, narrow
        bell-shaped chest, lack of ossification in pelvis and normal ossification
        of the skull.
      explanation: The case radiograph documents a bell-shaped thorax.
  - target: Reduced Fetal Lung Development
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Reduced intrathoracic space available for fetal lung growth
    description: >-
      Thoracic restriction is a recognized prenatal predictor of reduced lung
      volume; the specific ACG2 source establishes their co-occurrence.
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A rare, lethal type of achondrogenesis, and part of the spectrum of type
        2 collagen-related bone disorders, characterized by severe micromelia,
        short neck with large head, small thorax, protuberant abdomen,
        underdeveloped lungs, distinctive facial features such as a prominent
        forehead, a small chin, a cleft palate (in some) and distinctive
        histological features of the cartilage.
      explanation: The subtype definition associates the small thorax with underdeveloped lungs.
    - reference: PMID:34019743
      reference_title: 'Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.'
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        It is possible to use prenatal ultrasonography to observe predictors of
        lethality, such as a bell-shaped thorax, short ribs, severe femoral
        shortening, and decreased lung volume.
      explanation: General prenatal skeletal-dysplasia evidence links thoracic restriction with reduced lung volume.

- name: Reduced Fetal Lung Development
  description: >-
    Restricted thoracic growth is accompanied by pulmonary hypoplasia, leaving
    insufficient respiratory reserve after birth.
  biological_processes:
  - preferred_term: lung development
    term:
      id: GO:0030324
      label: lung development
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0002089 | Pulmonary hypoplasia | Frequent (79-30%)
    explanation: The subtype record supports pulmonary hypoplasia.
  downstream:
  - target: Pulmonary Hypoplasia
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:93296
      reference_title: Achondrogenesis type 2
      supports: SUPPORT
      evidence_source: OTHER
      snippet: HP:0002089 | Pulmonary hypoplasia | Frequent (79-30%)
      explanation: The subtype record supports the phenotype endpoint.
  - target: Perinatal Respiratory Failure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Insufficient lung volume and gas-exchange capacity
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Apart from skeletal anomalies, severe pulmonary hy-poplasia occurs in
        ACG2 due to the underlying defects in collagen expression, and
        respiratory distress can occur immediately after birth with severe forms
        of the disorder [2, 14].
      explanation: The report links pulmonary hypoplasia with immediate neonatal respiratory distress.

- name: Perinatal Respiratory Failure
  description: >-
    Pulmonary hypoplasia and thoracic restriction cause severe neonatal
    respiratory insufficiency, the proximate lethal pathway in liveborn cases.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The present case had significant respiratory distress immediately after birth,
      was followed with HFOV due to persistent respiratory distress during
      mechanical ventilation using conventional settings and the patient died of
      respiratory insufficiency on postnatal day 25.
    explanation: A molecularly confirmed liveborn case documents the respiratory lethal pathway.
  downstream:
  - target: Neonatal Respiratory Distress
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The present case had significant respiratory distress immediately after birth,
        was followed with HFOV due to persistent respiratory distress during
        mechanical ventilation using conventional settings and the patient died
        of respiratory insufficiency on postnatal day 25.
      explanation: The case directly documents immediate neonatal respiratory distress.
  - target: Respiratory Failure
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:31523626
      reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: The patient died of respiratory insufficiency on postnatal day 25.
      explanation: The case directly documents fatal respiratory insufficiency.

histopathology:
- name: Disorganized Growth Plate Cartilage
  description: >-
    Epiphyseal and growth-plate cartilage is replaced by heterogeneous,
    hypervascular tissue containing fibrous canals and abnormally enlarged
    chondrocytes.
  diagnostic: true
  evidence:
  - reference: PMID:3309860
    reference_title: Achondrogenesis type II, abnormalities of extracellular matrix.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The normal architecture of the epiphyseal and growth plate cartilage was
      replaced by a morphologically heterogeneous tissue.
    explanation: Seven ACG2 cases showed the characteristic cartilage disorganization.

imaging_findings:
- name: Prenatal ultrasound pattern of lethal skeletal underdevelopment
  modality: ULTRASOUND
  description: >-
    Prenatal ultrasound can detect severe long-bone shortening or micromelia,
    a small thorax, edema or hydrops, and polyhydramnios. These findings support
    suspicion of a lethal skeletal dysplasia but do not by themselves establish
    the molecular subtype.
  diagnostic: false
  evidence:
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the first pregnancy, severe micromelia and generalized edema were noted
      on ultrasound at 21 weeks' gestation.
    explanation: Documents prenatal sonographic detection of classic ACG2 findings.
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a detailed sonography scan revealed short long bones (<1st percentile for
      all long bones, including femur, tibia, fibula, humerus, radius and ulna)
      with a small thorax and polihydroamnios.
    explanation: A molecularly confirmed case documents the composite ultrasound pattern.
- name: Skeletal radiographic pattern of ACG2
  modality: XRAY
  description: >-
    Radiographs show short tubular bones with widened metaphyses, short usually
    unfractured ribs, a narrow bell-shaped thorax, and markedly deficient
    vertebral and pelvic ossification. Relative preservation of skull
    ossification can help distinguish classic ACG2, but it is not stated as
    invariant.
  diagnostic: true
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Radiographical findings: short tubular bone with widened metaphyses and
      non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped
      chest, lack of ossification in pelvis and normal ossification of the skull.
    explanation: A molecularly confirmed case documents the discriminating radiographic pattern.

genetic:
- name: COL2A1
  gene_term:
    preferred_term: COL2A1
    term:
      id: hgnc:2200
      label: COL2A1
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    Affected fetuses carry constitutional heterozygous COL2A1 variants. Many are
    new in the fetus, while transmission from a gonadal or somatogonadal mosaic
    parent is documented.
  variants:
  - name: Triple-helical glycine substitutions
    description: >-
      The predominant studied class replaces an obligatory glycine in the
      COL2A1 Gly-X-Y repeat with an amino acid having a bulkier side chain.
    evidence:
    - reference: PMID:10797431
      reference_title: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Ten of the mutations were single base substitutions that converted a
        codon for an obligate glycine to a codon for an amino acid with a
        bulkier side chain.
      explanation: Ten of 12 patients in this severe-spectrum series had glycine substitutions.
  - name: Splice-site and in-frame deletion variants
    description: >-
      Less common severe-spectrum variants alter a consensus splice site or
      delete coding sequence in frame.
    evidence:
    - reference: PMID:10797431
      reference_title: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        One of the mutations was a change in a consensus RNA splice site.
        Another was an 18-base pair deletion of coding sequences.
      explanation: The same series documents these non-glycine-substitution classes.
  evidence:
  - reference: CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
    reference_title: COL2A1 / achondrogenesis type II (Definitive)
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      COL2A1 | HGNC:2200 | achondrogenesis type II | MONDO:0008702 | AD |
      Definitive | SOP7 | Skeletal Disorders Gene Curation Expert Panel |
      2020-10-05T04:00:00.000Z
    explanation: ClinGen classifies the COL2A1 relationship as definitive.

phenotypes:
- name: Severe Micromelia
  description: Profound shortening of all limbs is a defining fetal feature.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Micromelia
    term:
      id: HP:0002983
      label: Micromelia
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0002983 | Micromelia | Frequent (79-30%)
    explanation: Orphanet lists micromelia as frequent in the subtype record.
- name: Short Long Bones
  description: Prenatal imaging and radiographs show profound shortening of all long bones.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Short long bone
    term:
      id: HP:0003026
      label: Short long bone
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0003026 | Short long bone | Very frequent (99-80%)
    explanation: Orphanet lists short long bones as very frequent.
- name: Hypoplastic Ilia
  description: The iliac bones are severely underdeveloped.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hypoplastic ilia
    term:
      id: HP:0000946
      label: Hypoplastic ilia
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0000946 | Hypoplastic ilia | Frequent (79-30%)
    explanation: Orphanet lists hypoplastic ilia as frequent.
- name: Absent Vertebral Body Mineralization
  description: Vertebral bodies can remain unmineralized in the severe axial phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Absent vertebral body mineralization
    term:
      id: HP:0004605
      label: Absent vertebral body mineralization
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0004605 | Absent vertebral body mineralization | Frequent (79-30%)
    explanation: Orphanet lists absent vertebral-body mineralization as frequent.
- name: Unossified Sacrum
  description: Sacral ossification is absent or profoundly deficient.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Unossified sacrum
    term:
      id: HP:0030290
      label: Unossified sacrum
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0030290 | Unossified sacrum | Frequent (79-30%)
    explanation: Orphanet lists unossified sacrum as frequent.
- name: Delayed Pubic Bone Ossification
  description: Pubic-bone ossification is markedly delayed or absent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Delayed pubic bone ossification
    term:
      id: HP:0008788
      label: Delayed pubic bone ossification
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0008788 | Delayed pubic bone ossification | Frequent (79-30%)
    explanation: Orphanet lists delayed pubic-bone ossification as frequent.
- name: Metaphyseal Widening
  description: Short tubular bones may have widened metaphyses.
  phenotype_term:
    preferred_term: Metaphyseal widening
    term:
      id: HP:0003016
      label: Metaphyseal widening
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an X-ray examination revealed a short tubular bone structure, metaphyseal
      widening, short ribs, a small chest and a lack of ossification in the pelvis
    explanation: A molecularly confirmed case documents metaphyseal widening.
- name: Narrow Chest
  description: Thoracic growth is severely restricted.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Narrow chest
    term:
      id: HP:0000774
      label: Narrow chest
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0000774 | Narrow chest | Frequent (79-30%)
    explanation: Orphanet lists narrow chest as frequent.
- name: Short Ribs
  description: Ribs are markedly short.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Short ribs
    term:
      id: HP:0000773
      label: Short ribs
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0000773 | Short ribs | Frequent (79-30%)
    explanation: Orphanet lists short ribs as frequent.
- name: Bell-Shaped Thorax
  description: The narrow thorax can have a bell-shaped radiographic contour.
  phenotype_term:
    preferred_term: Bell-shaped thorax
    term:
      id: HP:0001591
      label: Bell-shaped thorax
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Radiographical findings: short tubular bone with widened metaphyses and
      non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped
      chest, lack of ossification in pelvis and normal ossification of the skull.
    explanation: A molecularly confirmed case documents a bell-shaped chest.
- name: Pulmonary Hypoplasia
  description: Underdeveloped lungs accompany the narrow thorax.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Pulmonary hypoplasia
    term:
      id: HP:0002089
      label: Pulmonary hypoplasia
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0002089 | Pulmonary hypoplasia | Frequent (79-30%)
    explanation: Orphanet lists pulmonary hypoplasia as frequent.
- name: Neonatal Respiratory Distress
  description: Liveborn infants can develop severe respiratory distress immediately after birth.
  phenotype_term:
    preferred_term: Neonatal respiratory distress
    term:
      id: HP:0002643
      label: Neonatal respiratory distress
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The present case had significant respiratory distress immediately after birth,
      was followed with HFOV due to persistent respiratory distress during
      mechanical ventilation using conventional settings and the patient died of
      respiratory insufficiency on postnatal day 25.
    explanation: A molecularly confirmed liveborn case documents immediate respiratory distress.
- name: Respiratory Failure
  description: Respiratory insufficiency is the proximate cause of neonatal death in liveborn cases.
  phenotype_term:
    preferred_term: Respiratory failure
    term:
      id: HP:0002878
      label: Respiratory failure
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The patient died of respiratory insufficiency on postnatal day 25.
    explanation: A molecularly confirmed liveborn case documents fatal respiratory insufficiency.
- name: Pulmonary Hypertension
  description: >-
    Pulmonary hypertension is retained as an untyped, single-case neonatal
    complication without a frequency or pulmonary-arterial-subtype claim.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: An echocardiography performed on postnatal day 4 revealed pulmonary hypertension
    explanation: A molecularly confirmed liveborn case documents pulmonary hypertension.
- name: Pierre-Robin Sequence
  description: Micrognathia with the Pierre-Robin sequence can accompany the craniofacial phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Pierre-Robin sequence
    term:
      id: HP:0000201
      label: Pierre-Robin sequence
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0000201 | Pierre-Robin sequence | Frequent (79-30%)
    explanation: Orphanet lists Pierre-Robin sequence as frequent.
- name: Midface Retrusion
  description: Midfacial flattening or retrusion contributes to the characteristic profile.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Midface retrusion
    term:
      id: HP:0011800
      label: Midface retrusion
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: HP:0011800 | Midface retrusion | Frequent (79-30%)
    explanation: Orphanet lists midface retrusion as frequent.
- name: Prominent Forehead
  description: A prominent forehead contributes to the characteristic craniofacial appearance.
  phenotype_term:
    preferred_term: Prominent forehead
    term:
      id: HP:0011220
      label: Prominent forehead
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A physical examination revealed extremely short extremities, abdominal
      distention, a small chest, a prominent forehead and a flat nasal bridge
      (Figure 1).
    explanation: A molecularly confirmed liveborn case documents a prominent forehead.
- name: Cleft Palate
  description: Cleft palate occurs in a subset of affected fetuses.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: ORPHA:93296
    reference_title: Achondrogenesis type 2
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A rare, lethal type of achondrogenesis, and part of the spectrum of type 2
      collagen-related bone disorders, characterized by severe micromelia, short
      neck with large head, small thorax, protuberant abdomen, underdeveloped
      lungs, distinctive facial features such as a prominent forehead, a small
      chin, a cleft palate (in some) and distinctive histological features of
      the cartilage.
    explanation: The subtype definition states that cleft palate occurs in some cases.
- name: Relative Macrocephaly
  description: The head appears large relative to the profoundly shortened body.
  phenotype_term:
    preferred_term: Relative macrocephaly
    term:
      id: HP:0004482
      label: Relative macrocephaly
  evidence:
  - reference: PMID:20387359
    reference_title: Antenatal diagnosis of achondrogenesis type II.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large
      head, short neck and chest, prominent abdomen and short limbs.
    explanation: Supports relative head enlargement without importing a parent-group frequency.
- name: Short Neck
  description: A short neck is documented in type II cases.
  phenotype_term:
    preferred_term: Short neck
    term:
      id: HP:0000470
      label: Short neck
  evidence:
  - reference: PMID:20387359
    reference_title: Antenatal diagnosis of achondrogenesis type II.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large
      head, short neck and chest, prominent abdomen and short limbs.
    explanation: A type II case documents short neck without assigning a frequency.
- name: Protuberant Abdomen
  description: The abdomen appears prominent relative to the short trunk and narrow chest.
  phenotype_term:
    preferred_term: Protuberant abdomen
    term:
      id: HP:0001538
      label: Protuberant abdomen
  evidence:
  - reference: PMID:20387359
    reference_title: Antenatal diagnosis of achondrogenesis type II.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Prenatal ultrasonography at 22-weeks gestation revealed a fetus with large
      head, short neck and chest, prominent abdomen and short limbs.
    explanation: A type II case documents the prominent abdomen.
- name: Generalized Edema
  description: Generalized fetal edema can accompany the severe prenatal presentation.
  phenotype_term:
    preferred_term: Edema
    term:
      id: HP:0000969
      label: Edema
  evidence:
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the first pregnancy, severe micromelia and generalized edema were noted
      on ultrasound at 21 weeks' gestation.
    explanation: A familial ACG2 report documents generalized edema without assigning a frequency.
- name: Hydrops Fetalis
  description: Hydrops can be an early prenatal manifestation.
  phenotype_term:
    preferred_term: Hydrops fetalis
    term:
      id: HP:0001789
      label: Hydrops fetalis
  evidence:
  - reference: PMID:17994563
    reference_title: 'A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a
      septated cystic hygroma were obvious.
    explanation: A molecularly confirmed familial case documents hydrops without assigning a frequency.
- name: Fetal Cystic Hygroma
  description: Cystic hygroma can be detected in affected pregnancies.
  phenotype_term:
    preferred_term: Fetal cystic hygroma
    term:
      id: HP:0010878
      label: Fetal cystic hygroma
  evidence:
  - reference: PMID:17994563
    reference_title: 'A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The couple had a fourth pregnancy, and at 11 weeks fetal hydrops with a
      septated cystic hygroma were obvious.
    explanation: A molecularly confirmed familial case documents cystic hygroma.
- name: Polyhydramnios
  description: Excess amniotic fluid can accompany the fetal skeletal phenotype.
  phenotype_term:
    preferred_term: Polyhydramnios
    term:
      id: HP:0001561
      label: Polyhydramnios
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a detailed sonography scan revealed short long bones (<1st percentile for
      all long bones, including femur, tibia, fibula, humerus, radius and ulna)
      with a small thorax and polihydroamnios.
    explanation: A molecularly confirmed case documents polyhydramnios without assigning a frequency.

treatments:
- name: Case-Based Neonatal Respiratory Support
  description: >-
    Intensive ventilatory support may be attempted in a liveborn infant, and
    nitric oxide was used after pulmonary hypertension was found in one case.
    Evidence documents use, not reversal of pulmonary hypoplasia or a survival
    benefit.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Neonatal respiratory distress
    term:
      id: HP:0002643
      label: Neonatal respiratory distress
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient had severe respiratory distress, and follow-up was continued
      with high frequency oscillation ventilation (HFOV), as conventional
      mechanical ventilator settings failed to achieve the target saturation
      level.
    explanation: Documents intensive respiratory support in one molecularly confirmed liveborn case.
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      An echocardiography performed on postnatal day 4 revealed pulmonary
      hypertension and the patient was administered nitric oxide
    explanation: Documents nitric oxide administration after case-level pulmonary hypertension was found.
- name: Genetic Counseling and Mosaicism-Aware Recurrence Assessment
  description: >-
    Counseling should address dominant inheritance, the usual new-variant
    presentation, parental testing, and residual recurrence from gonadal or
    somatogonadal mosaicism.
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although, we could not evaluate the presence of this mutation in the first
      fetus, we strongly believe that our data are in favor of germline mosaicism
      as the most likely explanation for the recurrence of type II
      achondrogenesis in both sibs.
    explanation: Supports mosaicism-aware recurrence counseling.
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The family was provided genetic counseling related to the high suspicion
      of lethal skeletal dysplasia.
    explanation: Documents prenatal genetic counseling in a suspected lethal skeletal dysplasia pregnancy.

diagnosis:
- name: Prenatal Ultrasound Detection
  description: >-
    Ultrasound can identify a lethal skeletal dysplasia pattern, including
    severe micromelia or long-bone shortening, a small thorax, and fetal edema.
  evidence:
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the first pregnancy, severe micromelia and generalized edema were noted
      on ultrasound at 21 weeks' gestation.
    explanation: Supports prenatal ultrasound detection.
  - reference: PMID:20387359
    reference_title: Antenatal diagnosis of achondrogenesis type II.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Routine ultrasound screening made early detection and timely management
      possible.
    explanation: Supports ultrasound as an early detection method.
- name: Skeletal Radiographic Evaluation
  description: >-
    Fetal or neonatal radiographs characterize the pattern of short tubular
    bones, short unfractured ribs, narrow bell-shaped thorax, and deficient
    vertebral and pelvic ossification, helping distinguish ACG2 from other lethal
    skeletal dysplasias.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Radiographical findings: short tubular bone with widened metaphyses and
      non ossified cervical vertebrae, short unfractured ribs, narrow bell-shaped
      chest, lack of ossification in pelvis and normal ossification of the skull.
    explanation: Documents the discriminating skeletal radiographic pattern.
- name: COL2A1 Molecular Genetic Testing
  description: >-
    Identification of a pathogenic heterozygous COL2A1 variant confirms the
    molecular diagnosis and enables targeted testing in a subsequent pregnancy
    when a familial variant is known.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  evidence:
  - reference: PMID:10797431
    reference_title: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Mutations in the COL2A1 gene were found in all 12 patients.
    explanation: Supports high diagnostic yield in this ACG2/hypochondrogenesis series.
  - reference: PMID:15054848
    reference_title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular analysis of genomic DNA extracted from amniotic cells of the
      second fetus revealed heterozygosity for a 1340G > A missense mutation
      (G316D) in the COL2A1 gene.
    explanation: Demonstrates prenatal molecular confirmation from amniotic cells.

differential_diagnoses:
- name: Achondrogenesis type IA
  description: >-
    Achondrogenesis IA overlaps through profound fetal skeletal shortening and
    severe ossification defects.
  distinguishing_features:
  - Skull ossification is poor in type IA but relatively preserved in classic ACG2.
  - Rib fractures favor type IA; ACG2 classically has short unfractured ribs.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skull is not ossified in ACG1A, whereas there are mildly low ossified
      areas in ACG1B. Skull ossification is normal in ACG2, alongside decreased
      ossification in the pelvis and spine. Rib fractures are common in ACG1A,
      whereas short ribs are often without fractures in ACG2 [2, 4, 13].
    explanation: Provides the principal radiographic distinctions from type IA.
- name: Achondrogenesis type IB
  description: >-
    Achondrogenesis IB shares a severe fetal skeletal presentation.
  distinguishing_features:
  - Skull ossification is mildly reduced in type IB but relatively preserved in classic ACG2.
  evidence:
  - reference: PMID:31523626
    reference_title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skull is not ossified in ACG1A, whereas there are mildly low ossified
      areas in ACG1B. Skull ossification is normal in ACG2, alongside decreased
      ossification in the pelvis and spine.
    explanation: Provides the principal radiographic distinction from type IB.
- name: Hypochondrogenesis
  disease_term:
    preferred_term: hypochondrogenesis
    term:
      id: MONDO:0019669
      label: hypochondrogenesis
  description: >-
    Hypochondrogenesis occupies the less severe end of a lethal skeletal
    dysplasia spectrum with substantial radiographic and histologic overlap.
  distinguishing_features:
  - The ACG2-hypochondrogenesis boundary is continuous and may not be cleanly resolved.
  evidence:
  - reference: PMID:3717210
    reference_title: 'Achondrogenesis II-hypochondrogenesis: variability versus heterogeneity.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These findings suggest that hypochondrogenesis and achondrogenesis type II
      represent a spectrum with marked phenotypic variability.
    explanation: A 24-case study supports a continuous ACG2-hypochondrogenesis spectrum.

notes: >-
  Ocular and hearing phenotypes that occur across the broader type II collagen
  disorder spectrum are intentionally not assigned to this perinatal-lethal
  subtype without ACG2-specific ascertainment. Intracellular retention and
  collagen I/III replacement are modeled as variant-specific routes rather than
  universal ACG2 biology.

references:
- reference: CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T040000.000Z
  title: COL2A1 / achondrogenesis type II (Definitive)
- reference: ORPHA:932
  title: Achondrogenesis
- reference: ORPHA:93296
  title: Achondrogenesis type 2
- reference: PMID:10797431
  title: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
- reference: PMID:15054848
  title: 'Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.'
- reference: PMID:1515761
  title: 'Collagen type II in Langer-Saldino achondrogenesis: absence of major abnormalities in a less severe case.'
- reference: PMID:17994563
  title: 'A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.'
- reference: PMID:20387359
  title: Antenatal diagnosis of achondrogenesis type II.
- reference: PMID:22859705
  title: Hypertrophic chondrocytes have a limited capacity to cope with increases in endoplasmic reticulum stress without triggering the unfolded protein response.
- reference: PMID:26443184
  title: Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.
- reference: PMID:31523626
  title: Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
- reference: PMID:3309860
  title: Achondrogenesis type II, abnormalities of extracellular matrix.
- reference: PMID:34019743
  title: 'Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.'
- reference: PMID:3717210
  title: 'Achondrogenesis II-hypochondrogenesis: variability versus heterogeneity.'
- reference: PMID:7829510
  title: A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
📚

References & Deep Research

References

15
No top-level findings curated for this source.
ORPHA:932
Achondrogenesis
No top-level findings curated for this source.
ORPHA:93296
Achondrogenesis type 2
No top-level findings curated for this source.
PMID:10797431
Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
No top-level findings curated for this source.
PMID:15054848
Recurrence of achondrogenesis type II within the same family: evidence for germline mosaicism.
No top-level findings curated for this source.
PMID:1515761
Collagen type II in Langer-Saldino achondrogenesis: absence of major abnormalities in a less severe case.
No top-level findings curated for this source.
PMID:17994563
A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father.
No top-level findings curated for this source.
PMID:20387359
Antenatal diagnosis of achondrogenesis type II.
No top-level findings curated for this source.
PMID:22859705
Hypertrophic chondrocytes have a limited capacity to cope with increases in endoplasmic reticulum stress without triggering the unfolded protein response.
No top-level findings curated for this source.
PMID:26443184
Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.
No top-level findings curated for this source.
PMID:31523626
Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.
No top-level findings curated for this source.
PMID:3309860
Achondrogenesis type II, abnormalities of extracellular matrix.
No top-level findings curated for this source.
PMID:34019743
Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.
No top-level findings curated for this source.
PMID:3717210
Achondrogenesis II-hypochondrogenesis: variability versus heterogeneity.
No top-level findings curated for this source.
PMID:7829510
A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
No top-level findings curated for this source.

Deep Research

3
Disorder ▸

Disorder

  • Name: Achondrogenesis Type II
  • Category: Mendelian
  • Existing deep-research providers: cyberian-codex, perplexity
  • Existing evidence reference count in YAML: 33

Key Pathophysiology Nodes

  • Type II Collagen Structural Defect
  • Extracellular Matrix Deficiency
  • Type 2 Collagenopathy Spectrum
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1002/ar.24086
  • DOI:10.1002/dvdy.24131
  • DOI:10.1002/jemt.1070280505
  • DOI:10.1073/pnas.070050097
  • DOI:10.1111/dgd.12203
  • DOI:10.3389/fcell.2021.664168
  • DOI:10.3389/fmolb.2021.593310
  • PMID:11698112
  • PMID:1374906
  • PMID:15054848
  • PMID:1515761
  • PMID:15365990
  • PMID:15895462
  • PMID:17437277
  • PMID:17638425
  • PMID:18773462
  • PMID:30854241
  • PMID:31523626
  • PMID:3309860
  • PMID:41373627
Falcon ▸
Achondrogenesis Type II (ACG2): Disease Characteristics Research Report
Edison Scientific Literature 20 citations 2026-05-29T21:06:30.722577

Achondrogenesis Type II (ACG2): Disease Characteristics Research Report

1. Disease Information

Overview / definition

Achondrogenesis type II (ACG2), also known as Langer–Saldino achondrogenesis, is a lethal congenital skeletal dysplasia on the severe end of the type II collagenopathy spectrum, typically presenting prenatally with extreme short limbs and a small thorax and resulting in stillbirth or death in the early neonatal period due to pulmonary hypoplasia/respiratory failure. (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 3-4, kobayashi2022novelmissensecol2a1 pages 1-2)

Direct abstract-supported definition example: “Achondrogenesis Type 2 is a lethal skeletal dysplasia …” with typical findings including “short arms and legs, a small chest with short ribs, lung hypoplasia …” (dogan2019achondrogenesistype2 pages 3-4)

Key identifiers

  • OMIM: 200610 (Achondrogenesis type II) (kobayashi2022novelmissensecol2a1 pages 1-2, barathouari2016mutationupdatefor pages 1-2)
  • Gene (OMIM): COL2A1 MIM 108300 (barathouari2016mutationupdatefor pages 1-2)
  • MeSH / Orphanet / ICD-10 / ICD-11 / MONDO: Not found in retrieved sources for this run (see artifact table). (kobayashi2022novelmissensecol2a1 pages 1-2)

Synonyms / alternative names

  • Achondrogenesis type II (ACG2) (kobayashi2022novelmissensecol2a1 pages 1-2)
  • Langer–Saldino achondrogenesis (maheshwari2021acasereport pages 1-3)
  • Achondrogenesis type II / hypochondrogenesis spectrum (korkko2000widelydistributedmutations pages 1-2)

Evidence sources used

The retrieved evidence includes both aggregated resources (variant/disease spectrum reviews and integrated variant analyses) and individual case reports/series (prenatal imaging and newborn presentations). (maheshwari2021acasereport pages 1-3, korkko2000widelydistributedmutations pages 1-2, barathouari2016mutationupdatefor pages 1-2, zhang2020integratedanalysisof pages 1-6)

2. Etiology

Disease causal factors

Primary cause: Germline pathogenic variants in COL2A1 (type II procollagen) causing type II collagenopathy with severe disruption of cartilage matrix and endochondral ossification. (barathouari2016mutationupdatefor pages 1-2, zhang2020integratedanalysisof pages 1-6)

Risk factors

  • Genetic: Presence of a heterozygous pathogenic COL2A1 variant is causal. A frequent causal class in severe phenotypes is glycine substitution within the triple-helical Gly-X-Y repeats. (barathouari2016mutationupdatefor pages 1-2, korkko2000widelydistributedmutations pages 1-2)
  • Non-genetic/environmental: No established environmental risk factors were identified in retrieved sources; ACG2 is primarily a monogenic disorder. (barathouari2016mutationupdatefor pages 1-2)

Protective factors / gene–environment interactions

No protective factors or gene–environment interactions were identified in the retrieved sources for ACG2. (barathouari2016mutationupdatefor pages 1-2)

3. Phenotypes (clinical + radiographic)

Typical timing and severity

ACG2 is typically prenatal-onset with severe skeletal abnormalities detectable on ultrasound and/or other fetal imaging, and the phenotype is severe and usually lethal. (maheshwari2021acasereport pages 1-3, kobayashi2022novelmissensecol2a1 pages 1-2)

Key prenatal phenotypes

Prenatal findings may include: * Severe limb shortening / micromelia (e.g., markedly low femur and humerus length Z-scores) (kobayashi2022novelmissensecol2a1 pages 1-2) * Thoracic hypoplasia/small chest, suggesting pulmonary hypoplasia risk (kobayashi2022novelmissensecol2a1 pages 1-2) * Cystic hygroma (reported in a 14-week fetus with ACG2) (kobayashi2022novelmissensecol2a1 pages 1-2) * Additional findings described in the broader ACG2/hypochondrogenesis fetal spectrum include hydrops and polyhydramnios. (korkko2000widelydistributedmutations pages 1-2)

Neonatal phenotypes

In liveborn infants, typical features include: * Short trunk, small/narrow chest, prominent/distended abdomen, and micromelia (dogan2019achondrogenesistype2 pages 3-4) * Severe respiratory distress due to pulmonary hypoplasia (dogan2019achondrogenesistype2 pages 3-4)

Hallmark radiographic phenotype (skeletal survey)

Classic radiographic findings reported across ACG2 cases include: * Very short long bones with widened/flared metaphyses (dogan2019achondrogenesistype2 pages 3-4) * Non-ossification or markedly decreased ossification of vertebral bodies (including cervical; and in some reports near-complete vertebral non-ossification) (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 3-4) * Short ribs (often without fractures) and narrow bell-shaped thorax (dogan2019achondrogenesistype2 pages 3-4) * Poor pelvic ossification with relatively preserved skull ossification (helpful discriminator vs some type I achondrogenesis forms) (dogan2019achondrogenesistype2 pages 3-4, dogan2019achondrogenesistype2 pages 4-5)

A representative post-termination radiograph showing these features (including vertebral non-ossification, flared metaphyses, cupped ribs, and iliac “paraglider” appearance) is available in the retrieved image evidence. (maheshwari2021acasereport media 016b7757)

Suggested HPO terms (examples)

Based on retrieved clinical/radiographic descriptions: * Micromelia, Short limb, Short long bones (maheshwari2021acasereport pages 1-3, kobayashi2022novelmissensecol2a1 pages 1-2) * Narrow thorax / thoracic hypoplasia, Short ribs, Bell-shaped thorax (dogan2019achondrogenesistype2 pages 3-4) * Pulmonary hypoplasia, Respiratory distress (dogan2019achondrogenesistype2 pages 3-4) * Abnormal vertebral ossification / absent vertebral ossification, Platyspondyly (conceptually consistent with near-complete absent vertebral ossification described) (maheshwari2021acasereport pages 1-3, maheshwari2021acasereport media 016b7757) * Cystic hygroma, Hydrops fetalis, Polyhydramnios (korkko2000widelydistributedmutations pages 1-2, kobayashi2022novelmissensecol2a1 pages 1-2)

Quality-of-life impact

Because ACG2 is typically perinatally lethal, longer-term quality-of-life outcomes are generally not applicable; for rare short-term survivors, quality of life is dominated by respiratory failure and intensive care needs. (dogan2019achondrogenesistype2 pages 3-4)

4. Genetic / Molecular Information

Causal gene(s)

  • COL2A1 (type II procollagen alpha-1 chain) is the principal causal gene for ACG2. (barathouari2016mutationupdatefor pages 1-2, zhang2020integratedanalysisof pages 1-6)

Inheritance pattern

ACG2 is described as autosomal dominant; many cases are de novo, but recurrence can occur due to parental germline mosaicism. (maheshwari2021acasereport pages 1-3, faivre2004recurrenceofachondrogenesis pages 4-5, kobayashi2022novelmissensecol2a1 pages 1-2)

Variant spectrum and classes (ACG2-relevant)

Aggregated evidence indicates that severe COL2A1 phenotypes (including ACG2/hypochondrogenesis) are enriched for dominant-negative glycine substitutions in the triple helix: * “One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats … [and] are common in achondrogenesis type II and hypochondrogenesis.” (barathouari2016mutationupdatefor pages 1-2)

A fetal case series found ACG2/HCG mutations distributed across the gene and reported classes including: * Glycine substitutions (10/12 in that cohort) * Splice-site mutation * In-frame deletion (18 bp) (korkko2000widelydistributedmutations pages 1-2)

Example pathogenic/likely pathogenic variants (HGVS)

Examples from retrieved primary reports: * NM_001844.5:c.2987G>A (p.Gly996Asp), classified “likely pathogenic (PS2+PM2+PP3+PP4)” in a fetus (kobayashi2022novelmissensecol2a1 pages 1-2) * c.2546G>A (p.Gly849Asp) (novel heterozygous missense) in a newborn (dogan2019achondrogenesistype2 pages 3-4)

Functional consequences and mechanistic interpretation

The dominant-negative triple-helix glycine substitutions are described as disrupting collagen structure: * “These mutations disrupt the collagen triple helix …” (barathouari2016mutationupdatefor pages 1-2)

Mechanistically, this is consistent with defective cartilage extracellular matrix formation and impaired endochondral ossification, producing the profound under-ossification and growth failure characteristic of ACG2. (barathouari2016mutationupdatefor pages 1-2, dogan2019achondrogenesistype2 pages 3-4)

Modifier genes / epigenetics / chromosomal abnormalities

No modifier genes, epigenetic drivers, or recurrent chromosomal abnormalities specific to ACG2 were identified in retrieved sources. (barathouari2016mutationupdatefor pages 1-2)

5. Environmental Information

No established environmental or infectious contributors are described in the retrieved sources; ACG2 is primarily a monogenic collagen disorder due to COL2A1 variants. (barathouari2016mutationupdatefor pages 1-2)

6. Mechanism / Pathophysiology

Causal chain (high-level)

  1. COL2A1 variant (often glycine substitution in triple helix; dominant-negative) (barathouari2016mutationupdatefor pages 1-2)
  2. Disrupted type II collagen triple-helix formation/structure and cartilage matrix integrity (barathouari2016mutationupdatefor pages 1-2)
  3. Abnormal cartilage growth plate biology (histology can show hypercellularity/enlarged chondrocytes and disrupted growth plate zonation) (faivre2004recurrenceofachondrogenesis pages 4-5)
  4. Failure of normal endochondral ossification → poor vertebral/pelvic ossification, markedly short long bones, short ribs, small thorax (maheshwari2021acasereport media 016b7757, dogan2019achondrogenesistype2 pages 3-4)
  5. Pulmonary hypoplasia from severely restricted thoracic development → perinatal respiratory failure and lethality (dogan2019achondrogenesistype2 pages 3-4)

Pathway/process ontology suggestions

  • GO biological processes (suggestions): extracellular matrix organization; collagen fibril organization; endochondral ossification; cartilage development (supported conceptually by COL2A1 cartilage role and growth plate pathology descriptions) (faivre2004recurrenceofachondrogenesis pages 4-5, zhang2020integratedanalysisof pages 1-6, barathouari2016mutationupdatefor pages 1-2)
  • Cell types (CL suggestions): chondrocyte (growth plate / cartilage) (faivre2004recurrenceofachondrogenesis pages 4-5)

Molecular profiling / single-cell / spatial / functional genomics

No ACG2-specific omics profiling (transcriptomic/proteomic/metabolomic) or single-cell/spatial studies were identified in retrieved sources for this run. (barathouari2016mutationupdatefor pages 1-2)

7. Anatomical Structures Affected

Organ/system level

Primary involvement is the skeletal system (long bones, ribs, spine, pelvis) with secondary lethal involvement of the respiratory system due to pulmonary hypoplasia. (dogan2019achondrogenesistype2 pages 3-4)

Tissue/cell level

Primary tissue pathology localizes to cartilage and the growth plate (disordered chondrocyte morphology/zoning). (faivre2004recurrenceofachondrogenesis pages 4-5)

UBERON suggestions

  • vertebral column/vertebral bodies; rib; pelvis/ilium; limb long bones; cartilage; lung (maheshwari2021acasereport media 016b7757, dogan2019achondrogenesistype2 pages 3-4)

8. Temporal Development

  • Onset: Congenital/prenatal; may be detectable in the first or second trimester depending on severity and imaging (e.g., 14-week fetus with severe limb shortening and cystic hygroma). (kobayashi2022novelmissensecol2a1 pages 1-2)
  • Course: Not progressive in the typical sense; disease is usually perinatally lethal. (dogan2019achondrogenesistype2 pages 3-4)

9. Inheritance and Population

Epidemiology

A radiology case report review states an estimated frequency of approximately 0.2 per 100,000 births for achondrogenesis type II. (maheshwari2021acasereport pages 1-3)

De novo occurrence and recurrence risk

Although many cases occur de novo, familial recurrence has been documented and attributed to germline mosaicism, which is important for counseling. (faivre2004recurrenceofachondrogenesis pages 4-5)

Population demographics (sex ratio, geographic distribution) were not available in the retrieved sources for this run. (barathouari2016mutationupdatefor pages 1-2)

10. Diagnostics

Prenatal diagnosis

Imaging: Obstetric ultrasound is the primary screening and diagnostic modality. In fetal skeletal dysplasia evaluation, fetal CT is also referenced as an option in the ACG2 context. (kobayashi2022novelmissensecol2a1 pages 1-2)

A quantitative example from a prenatal imaging case report: an extremely low femur length/abdominal circumference ratio (FL/AC) of 0.08 (vs typical 0.20–0.25) was used as a strong indicator of lethal skeletal dysplasia in a reported ACG2 case. (maheshwari2021acasereport pages 1-3)

Postnatal/postmortem confirmation

Radiographic skeletal survey demonstrates the diagnostic pattern of under-ossification and limb/rib/pelvic abnormalities. (maheshwari2021acasereport media 016b7757, dogan2019achondrogenesistype2 pages 3-4)

Genetic testing

ACG2 can be confirmed by NGS-based molecular diagnosis (COL2A1 sequencing within targeted panels or exome approaches) with confirmatory Sanger sequencing in reported cases. (dogan2019achondrogenesistype2 pages 3-4)

Differential diagnosis

Important differentials discussed in retrieved sources include: * thanatophoric dysplasia * osteogenesis imperfecta type II * hypophosphatasia congenita and distinction from achondrogenesis type I subtypes can be supported by radiographic patterns (e.g., relatively preserved skull ossification in ACG2 with decreased pelvic/vertebral ossification). (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 4-5)

11. Outcome / Prognosis

ACG2 is consistently described as lethal, with death occurring in utero or in the early neonatal period, largely due to pulmonary hypoplasia and respiratory failure. (dogan2019achondrogenesistype2 pages 3-4, barathouari2016mutationupdatefor pages 1-2)

A documented liveborn course illustrates the severity: a newborn with ACG2 required high-frequency ventilation and died in the neonatal period. (dogan2019achondrogenesistype2 pages 3-4)

12. Treatment

Disease-modifying therapy

No disease-modifying pharmacologic or molecular therapy for ACG2 was identified in retrieved sources for this run. (barathouari2016mutationupdatefor pages 1-2)

Supportive/palliative care

Management for liveborn infants is generally supportive (e.g., respiratory support in intensive care), but overall survival is poor. (dogan2019achondrogenesistype2 pages 3-4)

MAXO term suggestions (examples)

  • respiratory support
  • palliative care
  • neonatal intensive care
  • genetic counseling
  • prenatal molecular diagnosis

13. Prevention

Because ACG2 is genetic, “prevention” primarily consists of reproductive risk reduction and early detection: * Genetic counseling is emphasized in mutation-spectrum reviews as a critical component of care (“an early diagnosis is critical … and genetic counseling to affected families”). (barathouari2016mutationupdatefor pages 1-2) * Prenatal diagnosis in subsequent pregnancies may use targeted familial-variant testing (when known) plus fetal imaging. * Recurrence counseling should include the possibility of germline mosaicism. (faivre2004recurrenceofachondrogenesis pages 4-5)

Pregnancy termination after definitive diagnosis is discussed in lethal skeletal dysplasia case management contexts. (maheshwari2021acasereport pages 1-3)

14. Other Species / Natural Disease

No naturally occurring ACG2-equivalent disease in other species was identified in the retrieved sources for this run. (barathouari2016mutationupdatefor pages 1-2)

15. Model Organisms

No model organism studies specific to achondrogenesis type II were identified in the retrieved sources for this run (the retrieved literature focused on human case reports/series and human variant-spectrum analyses). (barathouari2016mutationupdatefor pages 1-2)

Summary tables (knowledge-base ready)

Section Item Details Ontology suggestions Evidence
Disease identifiers & synonyms Primary disease name Achondrogenesis type II; lethal congenital/perinatal skeletal dysplasia within the type II collagenopathy spectrum MONDO: Not found in retrieved sources (kobayashi2022novelmissensecol2a1 pages 1-2, maheshwari2021acasereport pages 1-3, barathouari2016mutationupdatefor pages 1-2)
Disease identifiers & synonyms Named subtype / synonyms Langer-Saldino achondrogenesis; ACG2; achondrogenesis type II/hypochondrogenesis spectrum MONDO: Not found in retrieved sources (maheshwari2021acasereport pages 1-3, korkko2000widelydistributedmutations pages 1-2)
Disease identifiers & synonyms Database identifiers available in retrieved evidence OMIM #200610 for achondrogenesis type II; COL2A1 MIM #108300 MeSH: Not found in retrieved sources; Orphanet: Not found in retrieved sources; ICD-10: Not found in retrieved sources; ICD-11: Not found in retrieved sources (kobayashi2022novelmissensecol2a1 pages 1-2, barathouari2016mutationupdatefor pages 1-2)
Disease identifiers & synonyms Evidence provenance Retrieved information is aggregated from disease-level and mutation review resources plus individual prenatal/newborn case reports, radiology reports, and molecular case series; not from EHR datasets — (kobayashi2022novelmissensecol2a1 pages 1-2, maheshwari2021acasereport pages 1-3, korkko2000widelydistributedmutations pages 1-2, barathouari2016mutationupdatefor pages 1-2)
Genetic / molecular Causal gene COL2A1 (collagen type II alpha 1 chain), encoding the alpha-1 chain of type II procollagen, the major collagen of cartilage HGNC gene symbol: COL2A1 (kobayashi2022novelmissensecol2a1 pages 1-2, barathouari2016mutationupdatefor pages 1-2, zhang2020integratedanalysisof pages 1-6)
Genetic / molecular Inheritance Typically autosomal dominant; many cases are de novo; recurrence can occur due to parental germline/somatic mosaicism — (maheshwari2021acasereport pages 1-3, faivre2004recurrenceofachondrogenesis pages 4-5, kobayashi2022novelmissensecol2a1 pages 1-2)
Genetic / molecular Typical pathogenic variant classes Predominantly heterozygous glycine substitutions in the triple-helical Gly-X-Y repeat; also splice-site variants and in-frame deletions reported Sequence ontology suggestions: missense_variant, splice_acceptor_variant, inframe_deletion (korkko2000widelydistributedmutations pages 1-2, barathouari2016mutationupdatefor pages 1-2)
Genetic / molecular Example variants (HGVS) c.2987G>A (p.Gly996Asp), likely pathogenic; c.2546G>A (p.Gly849Asp), novel; c.1267-2_1269del causing exon 21 skipping/in-frame deletion; familial recurrence reported with G316D — (kobayashi2022novelmissensecol2a1 pages 1-2, dogan2019achondrogenesistype2 pages 3-4, faivre2004recurrenceofachondrogenesis pages 4-5)
Genetic / molecular Mechanistic notes Glycine substitutions disrupt collagen triple-helix folding/assembly (dominant-negative effect), impair cartilage matrix formation, and underlie severe/lethal phenotypes; ACG2/hypochondrogenesis are among the most severe COL2A1 phenotypes, associated with neonatal death GO: collagen trimer assembly; extracellular matrix organization; CL: chondrocyte (barathouari2016mutationupdatefor pages 1-2, zhang2020integratedanalysisof pages 1-6)
Phenotype / anatomy Core prenatal findings Severe micromelia/short limbs, short humerus/femur, thoracic hypoplasia or small/narrow chest, cystic hygroma, hydrops/polyhydramnios, increased nuchal fold; may be detectable from first/second trimester HPO: Short limb, Micromelia, Narrow thorax, Cystic hygroma, Hydrops fetalis, Polyhydramnios; UBERON: limb, thoracic cage (kobayashi2022novelmissensecol2a1 pages 1-2, korkko2000widelydistributedmutations pages 1-2)
Phenotype / anatomy Core neonatal/physical findings Short trunk, prominent/distended abdomen, relatively large head/prominent forehead, small chin/midface hypoplasia, severe respiratory distress due to pulmonary hypoplasia HPO: Short trunk, Abnormal abdomen morphology, Frontal bossing, Micrognathia, Midface retrusion, Respiratory distress, Pulmonary hypoplasia; UBERON: abdomen, lung, skull (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 3-4)
Phenotype / anatomy Hallmark radiographic findings Very short long bones with widened/flared metaphyses; non-ossification or markedly reduced ossification of vertebral bodies (including cervical/sacral), lack of pelvic ossification, short unfractured ribs, narrow bell-shaped thorax, cupped ribs, iliac “paraglider” appearance; skull ossification usually relatively preserved compared with type I achondrogenesis HPO: Platyspondyly/abnormal vertebral ossification, Short rib, Bell-shaped thorax, Short long bone, Flared metaphysis, Abnormal iliac bone morphology; UBERON: vertebral body, rib, ilium, pelvis (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 3-4, maheshwari2021acasereport media 016b7757)
Phenotype / anatomy Tissue/cell focus Primary pathology localizes to cartilage/growth plate; histology shows hypercellular, hypervascular cartilage with enlarged chondrocytes and disorganized growth plate maturation CL: chondrocyte; UBERON: cartilage tissue, growth plate; GO: endochondral ossification (faivre2004recurrenceofachondrogenesis pages 4-5, barathouari2016mutationupdatefor pages 1-2)
Diagnostics Prenatal imaging Detailed obstetric ultrasound is first-line; fetal CT and sometimes MRI may assist characterization of skeletal dysplasia and thoracic/rib/ossification abnormalities MAXO: prenatal imaging evaluation; fetal ultrasonography; computed tomography (kobayashi2022novelmissensecol2a1 pages 1-2, hall2024fetalandperinatal pages 61-63)
Diagnostics Postnatal / postmortem confirmation Skeletal survey/radiography confirms classic ossification and limb/rib/pelvic abnormalities; pathology/histology may support classification MAXO: radiographic skeletal survey; pathologic examination (maheshwari2021acasereport pages 1-3, faivre2004recurrenceofachondrogenesis pages 4-5, maheshwari2021acasereport media 016b7757)
Diagnostics Molecular testing strategy Molecular confirmation by NGS-based testing (single-gene COL2A1, targeted skeletal dysplasia panels, clinical exome/WES); variants commonly confirmed by Sanger sequencing; exome sequencing increases diagnostic yield in fetuses with short long bones after negative karyotype/CMA MAXO: sequence analysis of COL2A1; exome sequencing; confirmatory Sanger sequencing (kobayashi2022novelmissensecol2a1 pages 1-2, dogan2019achondrogenesistype2 pages 3-4)
Diagnostics Differential diagnosis clues Distinguish from achondrogenesis type I, thanatophoric dysplasia, osteogenesis imperfecta type II, and hypophosphatasia congenita; preserved skull ossification with poor vertebral/pelvic ossification favors ACG2 over some type I forms MAXO: differential diagnostic assessment (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 4-5, dogan2019achondrogenesistype2 pages 3-4)
Management / prognosis / prevention Prognosis Usually lethal: many affected fetuses are stillborn or die in utero, immediately after birth, or in the early neonatal period; death is driven largely by pulmonary hypoplasia/respiratory failure HPO: Perinatal lethality; Pulmonary hypoplasia (maheshwari2021acasereport pages 1-3, dogan2019achondrogenesistype2 pages 3-4, barathouari2016mutationupdatefor pages 1-2, kobayashi2022novelmissensecol2a1 pages 1-2)
Management / prognosis / prevention Supportive care No disease-modifying therapy identified in retrieved evidence; neonatal management is supportive/palliative, including respiratory support when liveborn, but survival is generally poor MAXO: respiratory support; palliative care; neonatal intensive care (dogan2019achondrogenesistype2 pages 3-4, kobayashi2022novelmissensecol2a1 pages 1-2)
Management / prognosis / prevention Prevention / reproductive options Genetic counseling is recommended; prenatal diagnosis in future pregnancies via targeted molecular testing and fetal imaging; recurrence counseling should include possibility of germline mosaicism; pregnancy termination may be considered where legally/ethically appropriate after definitive diagnosis MAXO: genetic counseling; prenatal molecular diagnosis; prenatal ultrasound monitoring; reproductive counseling (maheshwari2021acasereport pages 1-3, faivre2004recurrenceofachondrogenesis pages 4-5, barathouari2016mutationupdatefor pages 1-2)
Research / real-world implementation Current implementations / studies A natural history study in children with type II collagen disorders and short stature is recruiting (NCT05408715), but retrieved evidence does not indicate an interventional trial specific to lethal ACG2 MAXO: natural history study enrollment (hall2024fetalandperinatal pages 61-63)

Table: This table condenses the retrieved evidence on Achondrogenesis type II into knowledge-base-ready fields covering identifiers, genetics, phenotype, diagnostics, and management. It is useful as a structured source map with ontology suggestions and per-row citation IDs.

Key real-world implementations and recent developments (emphasis on 2023–2024 where available)

  • A 2024 comprehensive resource on fetal and perinatal skeletal dysplasias highlights the role of multimodal fetal imaging and multidisciplinary evaluation for prenatal-onset skeletal dysplasia conditions and explicitly lists ACG2 within the COL2A1-related spectrum. (hall2024fetalandperinatal pages 61-63)
  • Routine clinical implementation relies on NGS-based molecular confirmation of COL2A1 variants alongside classic radiographic patterns; mutation-spectrum curation supports clinical interpretation and counseling. (barathouari2016mutationupdatefor pages 1-2, dogan2019achondrogenesistype2 pages 3-4)

URLs and publication dates (retrieved sources cited)

  • Barat-Houari et al. Human Mutation (Jan 2016). https://doi.org/10.1002/humu.22915 (barathouari2016mutationupdatefor pages 1-2)
  • Doğan et al. Balkan J Med Genet (Jun 2019). https://doi.org/10.2478/bjmg-2019-0001 (dogan2019achondrogenesistype2 pages 3-4)
  • Maheshwari et al. Egyptian J Radiol Nucl Med (Apr 2021). https://doi.org/10.1186/s43055-021-00479-0 (maheshwari2021acasereport pages 1-3)
  • Kobayashi et al. Human Genome Variation (Nov 2022). https://doi.org/10.1038/s41439-022-00218-5 (kobayashi2022novelmissensecol2a1 pages 1-2)
  • Hall et al. Fetal and perinatal skeletal dysplasias (Mar 2024; CRC Press/ArXiv entry). https://doi.org/10.1201/9781003166948 (hall2024fetalandperinatal pages 61-63)

Limitations of this report (evidence availability in this run)

  • Standard identifiers beyond OMIM (Orphanet, ICD-10/11, MeSH, MONDO) were not present in the retrieved full texts; they should be added via dedicated ontology/database lookup workflows. (kobayashi2022novelmissensecol2a1 pages 1-2)
  • No ACG2-specific interventional trials, omics studies, or model organism studies were retrieved/citable in this run; additional targeted searches would likely be required for those topics. (barathouari2016mutationupdatefor pages 1-2)

References

  1. (maheshwari2021acasereport pages 1-3): Saurabh Maheshwari, Dilip Ingole, Samar Chatterjee, Uddandam Rajesh, and Varun Anand. A case report of achondrogenesis type ii (langer-saldino achondrogenesis). Egyptian Journal of Radiology and Nuclear Medicine, Apr 2021. URL: https://doi.org/10.1186/s43055-021-00479-0, doi:10.1186/s43055-021-00479-0. This article has 2 citations.

  2. (dogan2019achondrogenesistype2 pages 3-4): P. Doğan, IG Varal, O. Gorukmez, M. Akkurt, and A. Akdağ. Achondrogenesis type 2 in a newborn with a novel mutation on the col2a1 gene. Balkan Journal of Medical Genetics, 22:89-94, Jun 2019. URL: https://doi.org/10.2478/bjmg-2019-0001, doi:10.2478/bjmg-2019-0001. This article has 7 citations.

  3. (kobayashi2022novelmissensecol2a1 pages 1-2): Yukari Kobayashi, Yuki Ito, Kosuke Taniguchi, Kana Harada, Michihiro Yamamura, Taisuke Sato, Ken Takahashi, Hiroshi Kawame, Kenichiro Hata, Osamu Samura, and Aikou Okamoto. Novel missense col2a1 variant in a fetus with achondrogenesis type ii. Human Genome Variation, Nov 2022. URL: https://doi.org/10.1038/s41439-022-00218-5, doi:10.1038/s41439-022-00218-5. This article has 4 citations.

  4. (barathouari2016mutationupdatefor pages 1-2): Mouna Barat-Houari, Guillaume Sarrabay, Vincent Gatinois, Aurélie Fabre, Bruno Dumont, David Genevieve, and Isabelle Touitou. Mutation update for col2a1 gene variants associated with type ii collagenopathies. Human Mutation, 37:7-15, Jan 2016. URL: https://doi.org/10.1002/humu.22915, doi:10.1002/humu.22915. This article has 173 citations and is from a domain leading peer-reviewed journal.

  5. (korkko2000widelydistributedmutations pages 1-2): J. Körkkö, J. Körkkö, D. Cohn, L. Ala‐kokko, L. Ala‐kokko, D. Krakow, D. Krakow, and D. Prockop. Widely distributed mutations in the col2a1 gene produce achondrogenesis type ii/hypochondrogenesis. American journal of medical genetics, 92 2:95-100, May 2000. URL: https://doi.org/10.1002/(sici)1096-8628(20000515)92:2<95::aid-ajmg3>3.0.co;2-9, doi:10.1002/(sici)1096-8628(20000515)92:2<95::aid-ajmg3>3.0.co;2-9. This article has 76 citations.

  6. (zhang2020integratedanalysisof pages 1-6): Boyan Zhang, Yue Zhang, Naichao Wu, Jianing Li, He Liu, and Jincheng Wang. Integrated analysis of col2a1 variant data and classification of type ii collagenopathies. Dec 2020. URL: https://doi.org/10.1111/cge.13680, doi:10.1111/cge.13680. This article has 61 citations and is from a peer-reviewed journal.

  7. (dogan2019achondrogenesistype2 pages 4-5): P. Doğan, IG Varal, O. Gorukmez, M. Akkurt, and A. Akdağ. Achondrogenesis type 2 in a newborn with a novel mutation on the col2a1 gene. Balkan Journal of Medical Genetics, 22:89-94, Jun 2019. URL: https://doi.org/10.2478/bjmg-2019-0001, doi:10.2478/bjmg-2019-0001. This article has 7 citations.

  8. (maheshwari2021acasereport media 016b7757): Saurabh Maheshwari, Dilip Ingole, Samar Chatterjee, Uddandam Rajesh, and Varun Anand. A case report of achondrogenesis type ii (langer-saldino achondrogenesis). Egyptian Journal of Radiology and Nuclear Medicine, Apr 2021. URL: https://doi.org/10.1186/s43055-021-00479-0, doi:10.1186/s43055-021-00479-0. This article has 2 citations.

  9. (faivre2004recurrenceofachondrogenesis pages 4-5): Laurence Faivre, Martine Le Merrer, Serges Douvier, Nicole Laurent, Christel Thauvin‐Robinet, Thierry Rousseau, Inge Vereecke, Paul Sagot, Anne‐Lise Delezoide, Paul Coucke, and Geert Mortier. Recurrence of achondrogenesis type ii within the same family: evidence for germline mosaicism. American Journal of Medical Genetics Part A, 126A:308-312, Apr 2004. URL: https://doi.org/10.1002/ajmg.a.20597, doi:10.1002/ajmg.a.20597. This article has 27 citations.

  10. (hall2024fetalandperinatal pages 61-63): Christine M Hall, Amaka C Offiah, Francesca Forzano, Mario Lituania, Gen Nishimura, and Valerie Cormier-Daire. Fetal and perinatal skeletal dysplasias. ArXiv, Mar 2024. URL: https://doi.org/10.1201/9781003166948, doi:10.1201/9781003166948. This article has 26 citations.

Artifacts

Perplexity ▸
Comprehensive Pathophysiology of Achondrogenesis Type II: Molecular Mechanisms and Disease Progression
sonar-deep-research 51 citations 2026-02-04T18:10:49.700801

Comprehensive Pathophysiology of Achondrogenesis Type II: Molecular Mechanisms and Disease Progression

Achondrogenesis Type II (ACG2), also known as Langer-Saldino achondrogenesis, represents the most severe form of skeletal dysplasia caused by heterozygous mutations in the COL2A1 gene, which encodes type II collagen.[1][3][4] This lethal condition manifests as severe micromelic dwarfism, incomplete ossification of the vertebral bodies and pelvis, and profound underdevelopment of the lungs, with approximately 85% of affected infants dying before birth or within the first few days of life due to respiratory failure.[28] The fundamental pathophysiology of ACG2 involves the production of structurally abnormal type II collagen molecules that fail to form proper fibrillar networks within the extracellular matrix of cartilage and other connective tissues, triggering cellular stress responses, impaired chondrocyte differentiation, and disrupted endochondral ossification. This report provides an in-depth examination of the molecular mechanisms, cellular consequences, and disease progression mechanisms that characterize achondrogenesis type II, integrating findings from recent molecular genetics, developmental biology, and clinical studies to establish a comprehensive understanding of this devastating genetic disorder.

Core Pathophysiological Mechanisms of Achondrogenesis Type II

The Genetic Foundation: COL2A1 Gene Mutations

Achondrogenesis Type II is caused exclusively by heterozygous mutations in the COL2A1 gene, which is located on chromosome 12 (12q13.11-q13.2) and consists of 54 exons spanning over 31.5 kilobases.[2][5][41] The COL2A1 gene provides comprehensive instructions for synthesizing the alpha-1(II) chain, the basic structural component of type II collagen, a homotrimeric protein composed of three identical alpha-1(II) polypeptide chains, each containing 1060 amino acid residues.[2][41] Unlike the autosomal recessive inheritance patterns observed in achondrogenesis types 1A and 1B, ACG2 exhibits autosomal dominant inheritance, meaning that a single mutated copy of the COL2A1 gene in each cell is sufficient to cause the severe phenotype.[1][4][16] Importantly, most cases of ACG2 (approximately 80% of achondrogenesis cases) arise from de novo mutations that occur spontaneously during the formation of reproductive cells in an affected individual's parent or during early embryonic development, meaning that affected individuals typically have no family history of the condition.[4][13][28] However, germline and somatic mosaicism have been documented in rare familial cases, creating complex recurrence risks for parents of affected individuals.[37][40]

The molecular spectrum of COL2A1 mutations in ACG2 encompasses a diverse array of genetic alterations, including point mutations (missense, nonsense, deletion, insertion, and frameshift mutations) and complex rearrangements, with more than 400 mutations currently described in public databases and scientific literature.[2][12] Among these mutations, missense mutations constitute the most common type, accounting for over 70% of all pathogenic variants identified in COL2A1-related disorders.[2][12] These missense mutations frequently target the highly conserved glycine residues within the Gly-X-Y repeat motif that characterizes the triple-helical domain of type II collagen, where the X and Y positions are typically occupied by proline and hydroxyproline residues respectively.[2][41] Glycine substitutions in the Gly-X-Y repeat are particularly disruptive because glycine, being the smallest amino acid with only a hydrogen atom as its side chain, is uniquely suited to fit within the tightly packed interior of the collagen triple helix.[2][31][34] When glycine residues are replaced by larger amino acids such as serine, alanine, arginine, aspartate, cysteine, glutamate, or valine, the resulting structural distortion severely destabilizes the triple helix.[31][34] Studies examining host-guest triple-helical peptides have demonstrated that any substitution for glycine results in dramatic destabilization of the triple helix, with melting temperature (Tm) decreasing from approximately 45°C for normal collagen to approximately 10°C for alanine and serine substitutions, and to below 0°C for arginine, valine, glutamate, and aspartate substitutions.[31]

A particularly illustrative example comes from recent case reports documenting novel mutations in ACG2. One documented case revealed a heterozygous missense variation c.2546G>A, p.Gly849Asp in COL2A1, which had never been previously described in scientific literature before its identification through next-generation sequencing.[3][43] This glycine-to-aspartate substitution at position 849 in the triple-helical domain exemplifies the dominant-negative mechanism characteristic of ACG2, where the altered collagen chain integrates into the trimeric collagen molecule and destabilizes the entire structure through its compromised geometry. In another familial case, a father with proven somatic mosaicism harbored a c.1037G>T (p.Gly346Val) mutation that resulted in glycine substitution with valine, a bulkier hydrophobic residue, and this mutation was transmitted to multiple affected offspring, producing the characteristic lethal phenotype.[40] These documented mutations illustrate the fundamental principle that glycine-substituting mutations in the triple-helical domain produce the most severe phenotypes through dominant-negative mechanisms, whereas other types of mutations may lead to milder presentations through different pathogenic mechanisms.

Triple-Helical Structure and Its Disruption in ACG2

The normal type II collagen molecule represents a remarkable structural feat of biomolecular engineering, consisting of three alpha-1(II) chains that wind together to form a stable, tightly packed triple helix with a distinctive left-handed twist at the individual chain level and a right-handed superhelical arrangement of the three chains.[2][41] The triple-helical conformation is stabilized by extensive hydrogen bonding between the polypeptide backbones of adjacent chains and by the geometric constraints imposed by the Gly-X-Y repeat pattern, where the small glycine residue can fit into the crowded interior of the helix while larger amino acids cannot.[31][34] The triple-helical region spans approximately 1000 amino acids, interrupted only at the termini by non-helical telopeptide regions: a 19-residue N-telopeptide and a 27-residue C-telopeptide that are crucial for initiating triple-helix formation and for subsequent cross-linking of mature collagen fibers.[2][41] This architectural precision is essential for type II collagen's biological functions, and disruption of the Gly-X-Y pattern through point mutations directly compromises the structural integrity of the triple helix.

In achondrogenesis type II, glycine-to-amino acid substitutions produce several interconnected consequences for collagen structure. Mutant type II collagen molecules exhibit altered electrophoretic mobility, indicating changes in their charge and hydrodynamic properties, and demonstrate relatively low thermostability compared with normal collagen, suggesting that the destabilized triple helix is more prone to unfolding and denaturation.[2][12][41] Additionally, mutant collagen molecules show markedly slow rates of secretion into the extracellular space, as the poorly formed triple helix is recognized by cellular quality control mechanisms and retained within the endoplasmic reticulum.[2][12] When mutant type II collagen chains do manage to reach the extracellular space, they participate in abnormal fibril assembly, forming malformed fibrils that cannot properly interact with other elements of the extracellular matrix such as proteoglycans, other collagens, and matricellular proteins.[2][12][41] The consequence is that the normally robust extracellular matrix scaffold, which is supposed to comprise approximately 95% collagen and constitute approximately 60% of the dry weight of mature cartilage, is severely compromised in its structural integrity and biomechanical competence.[2]

Molecular and Genetic Basis: Type II Collagen and its Pathophysiological Roles

Biosynthesis and Normal Function of Type II Collagen

Type II collagen, encoded by the COL2A1 gene, serves as the predominant structural component of hyaline cartilage extracellular matrix, where it provides tensile strength and shape stability to this specialized tissue.[2][5][41] Beyond cartilage, type II collagen is also the major protein component of the nucleus pulposus of intervertebral discs, the vitreous humor of the eye (approximately 70% of vitreous total protein content), and the structural elements of the inner ear, tissues that together underscore the widespread importance of type II collagen for normal development and function of multiple organ systems.[2][5][27][41] During normal skeletal development, type II collagen is synthesized by proliferating chondrocytes within the growth plates until these cells differentiate into hypertrophic chondrocytes, at which point the synthesis of type II collagen is downregulated in favor of type X collagen synthesis.[2][41]

The normal biosynthetic pathway for type II collagen begins with the transcription of the COL2A1 gene and translation of the primary transcript into pro-alpha-1(II) chains, which undergo extensive post-translational modifications including hydroxylation of proline and lysine residues, glycosylation of certain hydroxylysine residues, and removal of signal peptides.[5][41] Three pro-alpha-1(II) chains then associate in the endoplasmic reticulum through interactions involving their C-propeptide domains and triple-helix formation, which proceeds directionally from the C-terminal toward the N-terminal region, creating stable procollagen molecules.[2][5][41][58] These procollagen molecules are transported through the secretory pathway, modified further by enzymes in the Golgi apparatus (a particularly critical step that is disrupted in achondrogenesis type 1A due to TRIP11 mutations affecting Golgi function), and secreted into the extracellular space where they undergo processing to remove the terminal propeptides and create mature collagen molecules.[2] The mature collagen molecules then spontaneously self-assemble into fibrils, which further associate laterally to form larger fibrils and fibers that are cross-linked through lysine and hydroxylysine residue interactions to achieve maximum structural stability and biomechanical strength.[2][41]

Remarkably, type II collagen functions not merely as a passive structural scaffold but also as an active extracellular signaling molecule with profound regulatory effects on chondrocyte biology.[2][7][41][20][23] Specifically, type II collagen acts as an autocrine factor of proliferation and differentiation via multiple downstream effectors and a potent suppressor of chondrocyte hypertrophy and apoptosis through negative regulation of SMAD1 activity, a finding that has major implications for understanding how COL2A1 mutations disrupt normal endochondral ossification processes.[2][7][41] The primary cellular receptor for type II collagen is integrin β1 (ITGB1), which mediates chondrocyte-extracellular matrix interactions and initiates intracellular signaling cascades that influence chondrocyte differentiation, metabolism, and survival.[7][23] Recent studies have demonstrated that upon interaction between COL2A1 and ITGB1, the integrin receptor competes with bone morphogenetic protein (BMP) receptors for binding to SMAD1 and phosphorylates ERK1/2, both of which mechanisms suppress BMP-SMAD1-mediated chondrocyte hypertrophy.[7][23] This regulatory function becomes dramatically impaired in ACG2 when mutant type II collagen fails to assemble properly, depriving chondrocytes of the critical suppressive signals that normally maintain them in an appropriate state of differentiation and proliferation.

Mutation-Specific Pathogenic Mechanisms

The diversity of COL2A1 mutations in achondrogenesis type II results in disease through two primary molecular mechanisms: dominant-negative effects and haploinsufficiency, though dominant-negative effects account for the overwhelming majority of severe type II collagenopathies including ACG2.[2][12][33] The dominant-negative mechanism operates when mutant collagen chains incorporate into trimeric collagen molecules alongside normal chains, forming hybrid molecules in which the presence of even a single defective chain severely compromises the stability and function of the entire complex.[2][12][33][34] This explains why ACG2, caused by dominant-negative mutations, produces such severe phenotypes despite the presence of one normal COL2A1 allele producing normal collagen chains: the abnormal chains "poison" the collagen fibrils through their deleterious effects on triple-helix stability and proper fibril assembly.

In contrast, haploinsufficiency results from mutations that cause premature termination of translation through nonsense mutations, out-of-frame deletions, or splice-site mutations that lead to non-sense mediated decay of the mutant transcript and reduced synthesis of normal collagen.[2][12][33][36] These haploinsufficiency mutations lead to milder phenotypes because 50% reduction in normal collagen production is better tolerated than the presence of destabilizing mutant chains, which explains why conditions such as Stickler syndrome, associated with truncation mutations causing haploinsufficiency, present less severe skeletal involvement than ACG2.[2][12][33][36][44] Missense mutations that substitute amino acids other than glycine result in generally milder phenotypes compared with glycine substitutions, because these mutations typically cause localized protein instability and impaired proper function of type II collagen without completely disrupting triple-helix formation, resulting in production of some partially functional collagen molecules.[2][12][33]

Particularly severe phenotypes result from glycine-to-nonserine substitutions in the triple-helical domain, such as glycine-to-arginine, glycine-to-aspartate, or glycine-to-valine substitutions, which produce alternating zones of severe skeletal dysplasia.[2][12][26] Glycine-to-serine substitutions, though still producing severe phenotypes, appear to generate somewhat milder manifestations compared with other glycine replacements, suggesting that the specific chemical properties of the substituted amino acid determine the degree of triple-helix destabilization.[26][31] C-propeptide domain mutations represent an important subset of COL2A1 mutations that produce distinctive clinical phenotypes with prominent brachydactyly (short digits) and different patterns of skeletal involvement compared with triple-helical mutations, likely because the C-propeptide region plays a specialized role in assembly of stable trimeric collagen molecules and may possess signaling functions distinct from the triple-helical domain.[2][9][36]

Cellular and Molecular Mechanisms: Disrupted Chondrocyte Function and Cartilage Matrix Assembly

Endoplasmic Reticulum Stress and Chondrocyte Dysfunction

One of the most critical molecular consequences of COL2A1 mutations in achondrogenesis type II involves intracellular retention of misfolded procollagen and type II collagen in the endoplasmic reticulum (ER), leading to ER stress that severely compromises chondrocyte function and survival.[2][11][12][41] In normal chondrocytes, procollagen molecules fold properly in the ER and transit smoothly through the secretory pathway, but mutant type II collagen chains that fail to form stable triple helices are recognized by cellular quality control mechanisms (including unfolded protein response pathways) and retained within the ER.[2][11][12][41] This retention causes accumulation of misfolded protein aggregates within the ER lumen, triggering classical endoplasmic reticulum stress responses that include upregulation of heat-shock proteins, activation of the unfolded protein response (UPR) involving ATF4 and IRE1α signaling, and engagement of apoptotic pathways if the stress becomes severe enough.[2][11][12][41]

Transgenic mouse models bearing COL2A1 mutations demonstrate this mechanism directly: chondrocytes in affected animals show greatly extended cisternae of rough endoplasmic reticulum with obvious retention of procollagen and other secretory pathway proteins such as fibronectin, confirming that the mutation directly prevents proper trafficking of type II collagen.[2][12] This ER stress retention causes multiple downstream consequences for chondrocyte biology. First, endoplasmic reticulum stress sufficient to reduce proliferation rate at the growth plates, as documented in experimental systems and animal models, directly decreases the population expansion of chondrocytes necessary for normal bone elongation.[2][12][41] Second, ER stress triggers absence or marked reduction in the mRNA expression of critical chondrocyte marker genes, including Cdkn1a (cyclin-dependent kinase inhibitor involved in cell cycle regulation), Ihh (Indian hedgehog, crucial for growth plate morphogenesis), Fgfr3 (fibroblast growth factor receptor 3, which signals in response to FGF ligands), COL10A1 (type X collagen, a marker of hypertrophic differentiation), and Runx2 (runt-related transcription factor 2, essential for osteoblast differentiation).[2][12][41] This coordinated downregulation of multiple essential growth plate genes suggests that ER stress triggers a global suppression of the genetic programs required for normal chondrocyte development and endochondral ossification.

Abnormal Chondrocyte Differentiation and Growth Plate Disorganization

The consequence of ER stress and reduced expression of growth plate regulatory genes is profound disruption of the normal sequence and coordination of chondrocyte differentiation events within the growth plate, fundamentally altering the morphological organization and functional capacity of this critical developmental structure.[2][12][41] In normal growth plates, chondrocytes undergo a highly orchestrated differentiation program progressing from resting chondrocytes in the resting zone, through proliferating cells in the proliferative zone that arrange themselves into characteristic columns parallel to the axis of bone elongation, followed by pre-hypertrophic chondrocytes and finally hypertrophic chondrocytes in the hypertrophic zone that undergo terminal differentiation, calcify their surrounding cartilage matrix, and prepare the tissue for vascular invasion and osteoblast recruitment.[19][22][39][42] This columnar organization is essential for efficient endochondral ossification and normal bone elongation rates.

In ACG2, this normal growth plate architecture is severely disrupted. Pathological studies of growth plates from achondrogenesis type II fetuses reveal growth plates with severely reduced or completely absent columnar-zone formation, with chondrocytes showing marked disorganization and enlargement due to intracellular vacuolization.[2][14][41][45] Rather than forming orderly columns, chondrocytes are scattered haphazardly throughout aberrant cartilage tissue, and the characteristic progression of chondrocyte differentiation from resting to proliferative to hypertrophic states becomes indistinguishable.[2][14][41] Proliferative and hypertrophic zones of cartilage are either markedly shorter than normal or completely indistinguishable, indicating severe disruption of the temporal and spatial regulation of chondrocyte differentiation.[2][12][41] Furthermore, deposition of cartilage matrix is notably impaired, with collagen fibrils present in significantly reduced numbers and showing less elaborate architecture compared with normal cartilage, directly reflecting the failure of normal type II collagen to assemble into proper fibrillar networks.[2][12][41]

The abnormal chondrocyte differentiation that results from ACG2 mutations negatively affects linear bone growth through multiple mechanisms: the altered relationships between chondrocytes prevent them from providing proper mechanical and chemical signals to neighboring cells; the reduction in growth factors produced by abnormally differentiating chondrocytes impairs the endocrine-like actions that normally regulate growth plate function; and the disrupted extracellular matrix fails to bind and present growth factors like Indian hedgehog and BMP ligands in their normal spatiotemporal patterns.[2][12][41] The consequence is a growth plate that is fundamentally unable to direct normal bone elongation, resulting in the severe micromelic dwarfism that characterizes achondrogenesis type II.

Disrupted Extracellular Matrix Composition and Architecture

Beyond the intracellular retention of mutant collagen, the extracellular matrix itself becomes profoundly abnormal in achondrogenesis type II due to the inability of mutant type II collagen to form proper fibrillar networks and interact normally with other matrix components.[2][12][41][45] Histochemical and immunohistochemical analyses of cartilage from ACG2 cases reveal that while the tissue contains types I and II collagen, cartilage proteoglycans (primarily aggrecan), fibronectin, and various glycoconjugates, the normal spatial organization and fibrillar architecture are severely disrupted.[2][14][45] Normal hyaline cartilage derives 95% of its collagenous content from type II collagen, which self-assembles into fibrils that form the tensile load-bearing network of the tissue, but in ACG2, the mutant type II collagen molecules fail to form proper fibrils, and this failure leads to striking changes in matrix ultrastructure.[2][45]

At the ultrastructural level, electron microscopy studies of ACG2 cartilage demonstrate obvious reduction in collagen fibrils throughout the entire growth plate, with the fibrils that do form appearing structurally abnormal, having irregular cross-sections and reduced diameters compared with normal collagen fibrils.[2][41][45] This abnormal fibril morphology reflects the incorporation of defective collagen chains into fibrillar aggregates that lack the precise geometric organization of normal collagen fibrils, which are characterized by a distinctive quarter-stagger alignment pattern that contributes to their mechanical strength and water-binding capacity.[2] The consequence is that the extracellular matrix becomes gelatinous and soft, lacking the structural integrity normally provided by well-organized type II collagen fibrils.[2][3][15][45] This gelatinous matrix cannot properly support the weight of the developing fetus or infant, cannot transmit mechanical forces properly between cells and bones, and cannot bind and present growth factors and other regulatory molecules in their normal concentrations and spatial distributions.

The disorganized extracellular matrix also fails to support proper cell-matrix interactions mediated through integrins and other adhesion molecules. Normal interactions between chondrocytes and type II collagen through integrin β1 trigger signaling cascades that normally suppress chondrocyte hypertrophy and apoptosis through mechanisms involving SMAD1 inhibition and ERK1/2 activation.[7][23] The failure of these interactions due to absent or improperly organized type II collagen deprives chondrocytes of essential suppressive signals, likely contributing to the abnormal chondrocyte differentiation and increased apoptosis observed in ACG2 cartilage. Furthermore, other matrix components like proteoglycans and fibronectin cannot interact properly with abnormally structured type II collagen fibrils, as these interactions are highly dependent on the correct three-dimensional architecture of the collagen scaffold.[56] The result is loss of the normal synergistic interactions between matrix components that confer mechanical resilience, osmotic stability, and biological activity to healthy cartilage tissue.

Key Affected Cell Types and Tissues

Chondrocytes as the Primary Target Cells

Chondrocytes, the specialized cells that produce cartilage matrix, are the cellular populations most critically affected in achondrogenesis type II, as these cells are responsible for producing type II collagen in massive quantities during development and maintaining this crucial protein throughout life.[2][12][41][45] All forms of achondrogenesis preferentially affect skeletal development because chondrocytes are the cells that synthesize the vast majority of the body's type II collagen, and any disruption of this synthesis rapidly cascades into impaired skeletal development.[2][12][41] In addition to the general effects on all chondrocytes, the differentiation stages of chondrocytes show differential vulnerability: proliferating chondrocytes in the growth plate appear particularly affected by ER stress and reduced growth factor signaling, leading to abnormal cell cycle progression and impaired proliferation; pre-hypertrophic and hypertrophic chondrocytes appear to undergo premature or abnormal differentiation, contributing to the disorganized growth plate architecture.[2][12][41]

The fate of hypertrophic chondrocytes in normal development represents a recent area of significant revision in our understanding of skeletal biology. Traditionally, hypertrophic chondrocytes were thought to undergo apoptosis as terminal differentiation, to be followed by vascular invasion and replacement by osteoblasts derived from perichondrial precursors.[22] However, modern lineage-tracing studies using genetic tags to permanently mark and track cells have demonstrated that some hypertrophic chondrocytes survive and directly differentiate into osteoblasts and osteocytes, contributing substantially to the trabecular and cortical bone formed by endochondral ossification.[22] This revised understanding suggests that ACG2 may disrupt not only normal chondrocyte development but also the transition of hypertrophic chondrocytes to osteogenic fates, potentially explaining why ossification is so severely deficient in these infants beyond merely the failure of cartilage matrix production.

Fibroblasts and Other Connective Tissue Cells

While chondrocytes are the primary target cells, type II collagen is also produced by fibroblasts in certain contexts, particularly during wound healing and tissue remodeling.[2][5] In achondrogenesis type II, fibroblasts and other connective tissue cells are affected as secondary targets, as type II collagen from mutant alleles would be incorporated into any tissue attempting to produce this collagen isoform. However, because type II collagen is primarily synthesized in cartilage under normal conditions, systemic effects on fibroblasts appear less prominent than effects specifically on cartilage development. Nonetheless, the vitreous humor of the eye contains substantial amounts of type II collagen, and ocular complications are well-documented in some type II collagenopathies, though the specific ocular involvement in ACG2 may vary due to the lethality of the condition preventing survival to ages where some complications might develop.[27]

Anatomical Locations and Tissue-Specific Manifestations

The Skeletal System: Primary Site of Pathology

The skeletal system represents the primary anatomical location affected by achondrogenesis type II, as cartilage serves as the template for endochondral bone formation throughout the skeleton.[1][4][16][17][25][28] All forms of achondrogenesis feature short arms and legs (micromelia), a narrow chest (thoracic constriction), and underdeveloped lungs (pulmonary hypoplasia), consequences that follow directly from the failure of cartilage to develop normally.[1][4][16][17] In achondrogenesis type II specifically, skeletal findings include markedly reduced or absent ossification of vertebral bodies, sacrum, and pubic bones, while the skull typically shows normal or only slightly reduced ossification, a distinctive pattern that helps differentiate ACG2 from other skeletal dysplasias.[1][3][4][13][15][25] The ribs are characteristically short without fractures (in contrast to achondrogenesis type 1A, where rib fractures are typical), and the costochondral junctions show severe disorganization, reflecting the failure of cartilage to develop properly at the junctures between ribs and costal cartilage.[1][3][4][13][25]

The growth plates of long bones show the pathological changes described previously, with severe disorganization, reduced matrix deposition, and impaired chondrocyte differentiation, resulting in severely shortened long bones with metaphyseal widening visible on radiographs.[1][3][4][15][25] The vertebral column shows characteristic incomplete ossification, with individual vertebral bodies failing to form bone normally and instead consisting primarily of unossified cartilage.[1][3][4][15][25] This incomplete ossification of the vertebral column contributes to spinal instability and potentially impacts the development of neural structures, though the severity of ACG2 typically prevents comprehensive evaluation of neurological consequences. The pelvis is severely hypoplastic, with markedly reduced ossification of the pubic and ischial bones, reflecting global failure of endochondral ossification throughout this region.[1][3][4][13][15][25]

The chest is characteristically small and narrow, with a bell-shaped or barrel appearance in some cases, creating a severely restrictive ribcage that cannot expand normally to accommodate lung development.[1][4][15][25][28] This chest wall deformity represents one of the most clinically significant consequences of ACG2, as it directly leads to the pulmonary hypoplasia that causes respiratory failure and death in most affected infants. The narrowed thorax mechanically restricts lung expansion, preventing the lungs from reaching their normal volume and preventing the proper development of alveolar structures necessary for gas exchange.[28][51][53] Even infants who survive the immediate perinatal period face severe limitations in their pulmonary function due to the restrictive ribcage phenotype.

The Respiratory System: Secondary but Critical Target

While the lungs themselves are not directly affected by type II collagen mutations, they become severely compromised as a consequence of chest wall abnormalities that physically restrict their development, creating a severe mechanical restriction that leads to pulmonary hypoplasia (underdeveloped lungs) that represents the primary cause of death in achondrogenesis type II.[28][51][53][54] The severely narrowed thorax cannot expand to the volume required for normal lung development, and the underdeveloped lungs cannot generate sufficient gas exchange to oxygenate the blood and eliminate carbon dioxide. Affected infants present immediately after birth with severe respiratory distress and require intensive respiratory support, often including high-frequency oscillation ventilation (HFOV) rather than conventional mechanical ventilation, because the abnormal chest mechanics prevent adequate tidal volume generation even with conventional ventilator settings.[3][25][28]

The pathophysiology of respiratory failure in ACG2 involves multiple interconnected factors beyond simple lung hypoplasia. First, the mechanical properties of the ribcage are fundamentally altered due to abnormal cartilage development, resulting in a severely overcompliant chest wall that offers little outward recoil to counterbalance the opposing elastic forces of the lungs, leading to decreased functional residual capacity and tendency toward atelectasis.[51] Second, laryngotracheobronchomalacia (softening of the larynx, trachea, and bronchi due to insufficient cartilaginous support) may develop as a consequence of type II collagen involvement in the structural cartilage of these airways, further compromising airway patency and increasing airway resistance.[51] Third, the severely restricted thoracic volume limits the lung volume that can be achieved even with aggressive mechanical ventilation, creating a fundamental ceiling to oxygenation and ventilation capacity that cannot be overcome through increased ventilator support.[28][51]

Facial and Craniofacial Features

Achondrogenesis Type II features characteristic facial abnormalities that, while not directly involving skeletal development in the same way as the limbs and chest, reflect broader disruptions in cranial and facial cartilage development and tissue differentiation processes. Distinctive facial features include a prominent forehead (frontal bossing), a small chin (micrognathia), and a flattened facial profile, with the small chin particularly noteworthy as it may contribute to airway obstruction and feeding difficulties.[1][4][13][16][25][49] Cleft palate occurs in some cases, reflecting the involvement of type II collagen in palatal cartilage development, and represents an additional anatomical factor that can compromise airway patency and feeding ability.[1][4][16][25][49] In some cases, cystic hygroma (accumulation of lymphatic fluid in the neck region) has been documented prenatally, and increased nuchal thickness and fetal hydrops (generalized body edema) may develop in utero, likely due to obstruction of lymphatic drainage by the severely abnormal skeletal and connective tissue development.[1][4][13][25][49] One case report emphasizes that micrognathia with a flattened facial profile and hydrops fetalis are consistently described as characteristic prenatal ultrasound features of achondrogenesis type II, even though quantitative epidemiological data on the incidence of these specific features remain limited.[49]

Disease Progression and Clinical Timeline

Prenatal Course and Prenatal Diagnosis

Achondrogenesis Type II typically becomes detectable during prenatal imaging as early as 14-17 weeks of gestation using ultrasound screening, when the characteristic skeletal abnormalities first become apparent on ultrasonography.[1][4][16] Early prenatal detection is often triggered by the observation of severe shortening of long bones (micromelia) and abnormal limb proportions, which prompt more detailed skeletal evaluation.[4][49][50][53] As pregnancy progresses, additional findings become apparent, including poor mineralization of the vertebral bodies and pelvis, short ribs, and a characteristically narrow chest with reduced thoracic volume.[49][50][53] In many cases, fetal hydrops develops during the second and third trimesters, manifesting as increased nuchal translucency, skin edema, ascites, and pleural or pericardial effusions, likely due to impaired lymphatic drainage and possibly cardiac compromise secondary to the severe skeletal deformities.[1][4][13][25][49]

Prenatal diagnosis can be confirmed through genetic testing using next-generation sequencing (NGS) of fetal DNA obtained via cordocentesis, amniocentesis, or chorionic villus sampling, which can identify heterozygous COL2A1 mutations.[3][25][49][50] The application of targeted exome sequencing focusing on known skeletal dysplasia genes, or whole exome sequencing, allows rapid molecular confirmation of the diagnosis and enables specific genetic counseling regarding recurrence risk.[3] In some cases, somatic or germline mosaicism has been documented in unaffected parents of affected infants, meaning that parents with a COL2A1 mosaicism may have a recurrence risk higher than the standard 1% de novo risk, potentially up to 5-25% depending on the degree of mosaicism in the parental germline cells.[37][40] Post-mortem imaging with radiography or CT scanning in terminated pregnancies can reveal the characteristic skeletal dysplasia findings and supports precise phenotypic characterization for genetic interpretation.[50]

Neonatal Course and Early Postnatal Period

Infants with achondrogenesis type II born alive or born alive following delayed intrauterine death present at birth with obvious clinical features of severe skeletal dysplasia, including extreme micromelia (very short, abnormally positioned limbs), markedly short stature, a disproportionately large head, prominent forehead, small chin, a small thorax, a prominent/distended abdomen, and severe respiratory distress.[3][25][28][49] The APGAR scores are characteristically low due to severe respiratory depression, with affected infants often unable to achieve spontaneous respiration and requiring immediate endotracheal intubation and mechanical ventilation.[3][25][49] Birth weight may be near normal in some cases (creating the distinctive appearance of a normal-sized head with severely shortened limbs), while length is severely reduced, often at or below the 3rd percentile for gestational age, and head circumference may be at the 90-97th percentile due to the relative macrocephaly characteristic of the condition.[3][25][49]

Immediately after birth, affected infants face a cascade of life-threatening complications directly related to the anatomical abnormalities produced by defective type II collagen.[28][51][53][54] Most critically, respiratory failure develops due to the combination of pulmonary hypoplasia and chest wall restriction, requiring aggressive mechanical ventilation, often including high-frequency oscillation ventilation (HFOV) or other advanced ventilator strategies to achieve adequate gas exchange.[3][25][28][51] Even with aggressive respiratory support, the mechanical limitations of the severely restricted thorax typically prevent adequate oxygenation and ventilation, leading to hypoxemia and hypercarbia (elevated blood carbon dioxide) that progressively worsen over hours to days.[3][25][28] Some infants develop pulmonary hypertension as a consequence of chronic hypoxemia, further compromising cardiac output and oxygen delivery.[3][25] Additional complications may include difficulty establishing peripheral vascular access due to severe generalized edema, necessitating central venous catheterization (umbilical catheter) for intravenous therapy and parenteral nutrition.[3][25][49]

Progression to Death and Characteristic Survival Times

Unfortunately, achondrogenesis type II uniformly results in perinatal lethality, with up to 85% of affected fetuses dying before birth or within the first few hours to days after birth, and virtually no surviving infants beyond the first few weeks of life.[28][53] The prognosis for achondrogenesis type II is universally poor, with death occurring either in utero (as stillbirth), immediately at or within minutes of birth due to apnea or inability to establish respiration, or within hours to days of birth despite intensive medical support.[28][53] The median survival time for liveborn infants with achondrogenesis type II is extremely short, typically in the range of less than 24 hours to several days**, with only rare cases of infants surviving beyond 2-3 weeks, and even then only with continuous intensive respiratory support in the setting of a neonatal intensive care unit.[3][28][49]

The progressive mechanism of death in surviving infants involves inexorable worsening of respiratory failure due to the physical limitations imposed by the severely restricted thorax, which prevents adequate lung expansion regardless of ventilator support, combined with metabolic acidosis developing from tissue hypoxia and anaerobic metabolism. Over a period of hours to days, arterial oxygen saturation progressively declines despite escalating ventilator support, arterial carbon dioxide rises above normal levels (respiratory acidosis), and mixed acidosis develops as anaerobic metabolism generates lactate and other organic acids. The profound hypoxemia triggers multiple organ dysfunction, including cardiac arrhythmias, renal failure, hepatic dysfunction, and activation of coagulation cascades, creating irreversible multi-organ failure. Death typically results from intractable hypoxemia unresponsive to maximal mechanical ventilation and supplemental oxygen, often occurring after several days of futile intensive care support when the family and medical team determine that further aggressive intervention is not beneficial and comfort-focused care is initiated.[28][49]

Cellular Signaling Pathways Dysregulated in Achondrogenesis Type II

The BMP-SMAD1 Signaling Pathway and Loss of Chondrocyte Homeostasis

Recent molecular discoveries have revealed that type II collagen functions as an extracellular signaling molecule that actively suppresses chondrocyte hypertrophy through inhibition of bone morphogenetic protein (BMP) signaling, specifically the BMP-SMAD1 pathway, a finding with major implications for understanding how COL2A1 mutations disrupt normal skeletal development.[7][20][21][23][39][41][42] The BMP signaling pathway is initiated when BMP ligands bind to type I and type II BMP receptors on the chondrocyte surface, triggering receptor autophosphorylation and leading to phosphorylation of intracellular receptor-regulated SMADs (particularly SMAD1/5), which then form complexes with the common mediator SMAD (SMAD4), translocate to the nucleus, and activate transcription of BMP target genes involved in chondrocyte hypertrophy and osteoblast differentiation.[21][24][39] This BMP-SMAD1 signaling pathway normally promotes chondrocyte hypertrophy, mineralization of cartilage matrix, and progression toward endochondral ossification, making it essential for normal bone development.[21][24][39][42]

However, type II collagen actively suppresses this BMP-SMAD1 pathway through a sophisticated mechanism involving the major type II collagen receptor integrin β1 (ITGB1), which upon binding to type II collagen competes with BMP receptors for binding to SMAD1, thereby preventing SMAD1 phosphorylation and nuclear translocation.[7][23] Additionally, type II collagen activation of ITGB1 triggers ERK1/2 phosphorylation through downstream kinase cascades, and ERK1/2 phosphorylation further represses BMP-SMAD1 pathway activation through direct interaction with SMAD1.[7][23] The net result is that normal type II collagen in properly assembled fibrils acts as a potent suppressor of BMP-SMAD1 signaling, maintaining chondrocytes in a proliferative state and preventing premature hypertrophy.[7][23][41] This regulatory mechanism appears critical for proper growth plate structure and function, as conditional deletion of ITGB1 in chondrocytes results in accelerated chondrocyte hypertrophy and growth plate defects similar to those observed in type II collagenopathies.[7][23]

In achondrogenesis type II, the failure of mutant type II collagen to assemble into proper fibrils and to be present in adequate quantities in the extracellular matrix means that chondrocytes are deprived of the suppressive signals normally provided by type II collagen-integrin β1 interactions.[7][12][23][41] The consequence is that BMP-SMAD1 pathway signaling becomes abnormally elevated in ACG2 chondrocytes, leading to accelerated and aberrant hypertrophic differentiation, increased expression of hypertrophic markers, enhanced osteogenic gene expression, and increased chondrocyte apoptosis.[7][12][23][41] This loss of type II collagen-mediated suppression of BMP signaling represents a major mechanism through which ACG2 mutations disrupt normal endochondral ossification: rather than chondrocytes proceeding through a carefully orchestrated program of proliferation, pre-hypertrophic transition, hypertrophic differentiation, and then either apoptosis or osteogenic transformation, instead they undergo dysregulated hypertrophic differentiation driven by unopposed BMP-SMAD1 signaling. The aberrant hypertrophy, combined with the abnormal extracellular matrix, results in disorganized growth plates incapable of directing normal bone elongation.

Effects on Chondrocyte Proliferation and Metabolic Function

Beyond the effects on hypertrophy regulation, loss of type II collagen also impairs chondrocyte proliferation through multiple mechanisms. Normal chondrocyte proliferation is regulated by a complex interplay of positive signals (including Indian hedgehog/Ihh signaling, parathyroid hormone-related peptide/PTHrP signaling, FGF signaling in specific contexts, and BMP signaling in specific doses) and negative signals (including high-dose FGF signaling and type II collagen-mediated suppression of excess BMP signaling).[39][42] When type II collagen is absent or abnormally structured, chondrocytes lose a critical brake on BMP signaling that would normally constrain excessive proliferation and ensure that chondrocyte division occurs at appropriate rates matched to the developmental stage.[7][23][39][41][42] Additionally, the endoplasmic reticulum stress triggered by accumulation of misfolded procollagen directly reduces proliferation rates at the growth plates through mechanisms involving activation of the unfolded protein response and phosphorylation of eIF2α, leading to global translation attenuation and cell cycle arrest.[2][12][41]

The consequence is a growth plate where chondrocytes fail to proliferate normally despite having growth-promoting signals, creating a population bottleneck that severely limits the number of cells available to undergo differentiation and contribute to bone elongation. The reduction in chondrocyte number, combined with the impaired progression through normal differentiation stages, results in severely shortened long bones and overall dwarfism.[2][12][41]

Disrupted Indian Hedgehog and Parathyroid Hormone-Related Peptide Signaling

The Indian hedgehog/parathyroid hormone-related peptide (Ihh/PTHrP) negative feedback loop represents another critical regulatory system disrupted in achondrogenesis type II.[2][39][41][42] In normal growth plates, Indian hedgehog is secreted by pre-hypertrophic and hypertrophic chondrocytes and acts to stimulate expression of parathyroid hormone-related peptide in perichondrial cells and in the resting zone chondrocytes, and parathyroid hormone-related peptide then diffuses back into the growth plate where it suppresses further Ihh expression and maintains a proliferative chondrocyte phenotype, preventing premature hypertrophy.[2][39][41][42] This feedback loop is essential for maintaining the normal thickness and organized structure of the growth plate's proliferative zone and for ensuring that chondrocytes do not undergo hypertrophic differentiation prematurely.[39][42]

The endoplasmic reticulum stress and abnormal chondrocyte differentiation occurring in ACG2 appear to severely disrupt the normal expression and spatial organization of Ihh and PTHrP, as documented by marked reduction or complete absence of Ihh mRNA expression in growth plates of affected individuals.[2][12][41] The loss of Ihh expression disrupts the feedback loop that normally maintains proliferative chondrocytes and prevents premature hypertrophy, leading to disorganization of the proliferative zone and inappropriate hypertrophic differentiation of chondrocytes that should remain proliferative.[2][12][41] This disruption of the Ihh/PTHrP feedback loop represents an additional mechanism through which ACG2 mutations produce the characteristic disorganized growth plate phenotype with loss of normal columnar architecture and impaired bone elongation.

Genotype-Phenotype Correlations in Achondrogenesis Type II

Spectrum of COL2A1 Mutations and Their Clinical Consequences

Achondrogenesis Type II demonstrates remarkable genotypic diversity, with more than 570 different mutations documented in the COL2A1 gene in scientific literature and public databases, and this genetic diversity correlates imperfectly with clinical phenotype severity.[2][3][12][26][33][43] Understanding the genotype-phenotype correlation is critical for explaining why some fetuses with ACG2 mutations might be stillborn with severe hydrops while others survive the immediate neonatal period with intensive support, though all uniformly have lethal outcomes eventually.[33] The most common mutations (over 70% of cases) are missense mutations, particularly those resulting in glycine substitutions in the Gly-X-Y repeat of the triple-helical domain, and these glycine substitutions produce the most severe phenotypes through dominant-negative mechanisms.[2][12][26][33]

Among missense mutations causing glycine substitutions, glycine-to-serine substitutions appear to produce slightly milder skeletal phenotypes compared with glycine-to-aspartate, glycine-to-arginine, or glycine-to-valine substitutions, suggesting that the specific chemical properties of the substituted amino acid influence the degree of triple-helix destabilization and thus the severity of the skeletal dysplasia.[2][12][26][31][33][34] For example, in one comparative analysis, glycine-to-serine substitutions resulted in alternating zones producing severer and milder skeletal phenotypes, whereas glycine-to-nonserine residue substitutions exclusively created more severe phenotypes without such alternating severity zones.[26] However, even the "milder" glycine-to-serine mutations in ACG2 still produce lethal skeletal dysplasia indistinguishable from other ACG2 mutations in terms of lethality and clinical course, suggesting that phenotypic variation among ACG2 cases is more about variation in survival time and degree of organ dysfunction rather than fundamental differences in skeletal dysplasia severity.[26][33][43]

Missense mutations affecting positions within the C-propeptide domain of type II collagen (the C-terminal propeptide region) produce distinctive skeletal phenotypes that differ from triple-helical domain mutations, characterized prominently by brachydactyly (abnormally short digits) and metaphyseal involvement in addition to spinal abnormalities, reflecting the distinct role of the C-propeptide in procollagen assembly and possible specific signaling functions of this domain.[2][9][33][36] The C-propeptide also known as chondrocalcin appears to play a role in growth plate development and potentially in regulation of chondrocyte proliferation, and mutations disrupting this region produce phenotypes with more prominent short-digit abnormalities than typical triple-helical mutations.[2][9]

Clinical Variability Among ACG2 Cases

Despite the severe and uniformly lethal nature of achondrogenesis type II, some degree of clinical variability exists in the severity of skeletal dysplasia, the degree of organ involvement (particularly respiratory), and the timing and rapidity of progression to respiratory failure.[33][43][49] Some ACG2 cases present with more severe in-utero manifestations including very early-onset hydrops fetalis and fetal demise in mid-pregnancy, while others allow survival to term or near-term with delivery of a liveborn but severely compromised infant.[3][25][28][49] Some fetuses present with mild to absent hydrops and normal skull ossification but severe limb shortening and vertebral non-ossification, while others develop prominent hydrops with cystic hygroma and generalized edema.[3][25][49] Once born, some ACG2 infants survive only hours due to immediate respiratory failure refractory to all interventions, while others survive for days or even up to several weeks with intensive respiratory support before ultimately succumbing to respiratory failure or multi-organ dysfunction.[3][25][28][49]

This clinical variability likely reflects inter-individual differences in the specific COL2A1 mutation and its precise effects on collagen structure, differences in the timing of mutation occurrence during germ cell or early embryonic development (affecting the degree of mosaicism if present), and potentially differences in genetic background factors affecting modifier gene expression and physiological resilience.[33][37][40][43] One documented case of achondrogenesis type II in a liveborn infant survived for 25 days with intensive support despite having a novel mutation, illustrating that rare infants with severe ACG2 can survive beyond the immediate neonatal period with dedicated intensive care.[3][25] However, survival beyond a few weeks appears extraordinarily rare, and no documented cases of long-term survival into childhood exist, making ACG2 uniformly fatal in the short term despite variation in the exact timing and pace of decline.[28][49]

Conclusion: Integrating Mechanisms from Genomics to Clinical Phenotype

Achondrogenesis Type II represents one of the most severe skeletal dysplasias, caused by heterozygous COL2A1 gene mutations that disrupt type II collagen structure and function through dominant-negative mechanisms.[1][2][3][4] The fundamental pathophysiology involves the production of structurally abnormal type II collagen molecules that fail to form stable triple helices, become retained in the endoplasmic reticulum triggering ER stress, and fail to assemble into functional fibrillar networks in the extracellular matrix.[2][12][41] This primary molecular defect cascades into profound disruption of multiple interconnected cellular and developmental processes: chondrocytes experience ER stress that reduces proliferation and triggers apoptosis; abnormal chondrocyte differentiation disrupts normal growth plate architecture; dysregulated BMP-SMAD1 signaling due to loss of type II collagen-mediated suppression causes aberrant hypertrophy; disruption of Indian hedgehog and PTHrP signaling further disorganizes the growth plate; and the gelatinous, poorly organized extracellular matrix fails to provide proper mechanical support or present growth factors in normal spatial distributions.[2][7][12][23][39][41][42]

The consequence of these dysregulated molecular and cellular processes is severe micromelic dwarfism, narrow thorax with underdeveloped lungs, incomplete ossification of vertebral bodies and pelvis, and characteristic facial features including frontal bossing and micrognathia.[1][3][4][13][25][28] Most critically from a clinical perspective, the narrow thorax and pulmonary hypoplasia create a fatal combination in which the severely restricted ribcage physically prevents adequate lung expansion, leading to respiratory failure that is uniformly fatal within hours to days of birth in most cases, with rare exceptions allowing survival for several weeks with intensive respiratory support but inevitable progression to fatal respiratory failure.[3][28][49][53] The identification of novel COL2A1 mutations through next-generation sequencing continues to expand our understanding of the genotype-phenotype correlations in this condition and increasingly provides opportunities for molecular diagnosis during pregnancy, enabling informed genetic counseling and family planning despite the universally lethal nature of the condition.[3][43][49]